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Abstract
The past decade has brought many advances in our understanding of GABAA receptor-mediated
ethanol action in the central nervous system. We now know that specific GABAA receptor subtypes
are sensitive to ethanol at doses attained during social drinking while other subtypes respond to
ethanol at doses attained by severe intoxication. Furthermore, ethanol increases GABAergic
neurotransmission through indirect effects, including the elevation of endogenous GABAergic
neuroactive steroids, presynaptic release of GABA, and dephosphorylation of GABAA receptors
promoting increases in GABA sensitivity. Ethanol’s effects on intracellular signaling also influence
GABAergic transmission in multiple ways that vary across brain regions and cell types. The effects
of chronic ethanol administration are influenced by adaptations in GABAA receptor function,
expression, trafficking, and subcellular localization that contribute to ethanol tolerance, dependence,
and withdrawal hyperexcitability. Adolescents exhibit altered sensitivity to ethanol actions, the
tendency for higher drinking and longer lasting GABAergic adaptations to chronic ethanol
administration. The elucidation of the mechanisms that underlie adaptations to ethanol exposure are
leading to a better understanding of the regulation of inhibitory transmission and new targets for
therapies to support recovery from ethanol withdrawal and alcoholism.
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Introduction
The past decade has brought many advances in our understanding of ethanol’s acute and chronic
actions mediated by gamma-aminobutyric acid type A (GABAA) receptors in the central
nervous system (CNS). The field has uncovered the GABAergic mechanisms that underlie
many of the behavioral effects of ethanol, including its anxiolytic, anticonvulsant, sedative-
hypnotic, cognitive-impairing, and motor incoordinating actions. These mechanisms include
direct and indirect effects on GABAA receptors as well as effects on GABA release and the
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synthesis and availability of endogenous neuroactive steroids. The effects of chronic ethanol
exposure have also been more clearly elucidated in rodents, monkeys, and humans, and there
is a better understanding of the intracellular mechanisms that mediate adaptations of
GABAA receptors to ethanol. The purpose of this article is to highlight the advances of the
past decade and to underscore new insights into the mechanisms of ethanol’s actions and
adaptations, particularly for their therapeutic relevance in the development of medications to
support recovery from ethanol dependence and treatment of alcoholism.
GABAA receptors are a family of chloride ion channels that predominately mediate rapid
inhibitory neurotransmission throughout the CNS. The neurotransmitter GABA binds to these
receptors, changing their conformation state and thereby opening the pore to allow chloride
ions (Cl−) to pass down an electrochemical gradient. The flux of chloride ions hyperpolarizes
the membrane leading to neuronal inhibition. However, it should be noted that, in developing
animals, neurons have a higher intracellular chloride concentration at an early stage leading to
an efflux of chloride and excitatory actions of GABA in immature neurons (Ben-Ari 2002).
GABAA receptors are heteromeric protein complexes consisting of several homologous
membrane-spanning glycoprotein subunits. Molecular cloning has revealed multiple
GABAA receptor subunits that can be divided by homology into subunit classes with several
members: α(1–6), β(1–3), γ(1–3), δ, ε, θ, π, and ρ(1–3) (Olsen and Sieghart 2008; Sieghart and
Sperk 2002). The large number of GABAA receptor subunits generates the potential for various
subunit compositions that may account for variable sensitivity to modulatory drugs such as
benzodiazepines, barbiturates, neuroactive steroids, and possibly ethanol and general
anesthetics. The GABAA receptor α1 subunit is the most abundant α subunit in adult brain,
highly expressed throughout most brain regions and is a component of ~50% of all GABAA
receptors (Kralic et al. 2002a). The analysis of subunit composition by co-immunoprecipitation
studies has demonstrated that 98% of α1 subunit-containing receptors are assembled with a γ
or δ subunit (Sieghart and Sperk 2002). In contrast, a significant fraction of α4 subunit-
containing receptors are comprised of α4 and β subunits only (Bencsits et al. 1999). GABAA
receptors also associate with various other proteins that anchor the receptor, regulate
phosphorylation state and trafficking, and modulate receptor function under various conditions.
These protein interactions are not yet well understood but clearly influence GABAA receptor
assembly, expression on the membrane surface, endocytosis, and channel function that
ultimately controls the inhibitory tone of the CNS.
GABAA receptors can exist as either synaptic or extrasynaptic receptors that may facilitate
rapid changes in inhibition. Most synaptic GABAA receptors are composed of two α, two β,
and one γ subunit, where the γ subunit is located between an α and β subunit (Sieghart et al.
1999; Tretter et al. 1997) and contribute to synaptically mediated (phasic) inhibition. In
contrast, tonic inhibition is due to highly sensitive GABAA receptors, activated by ambient
extracellular GABA or from ‘spillover’ of GABA from synaptic signaling, thought to be in the
range of 100 nM to 1 μM (Santhakumar et al. 2006; Tossman et al. 1986). The subunit
composition of GABAA receptors at synaptic and extrasynaptic sites are thought to be different.
Studies have shown that the α1 subunit is usually expressed in synaptic GABAA receptors
while the α4 subunit predominantly occurs in extrasynaptic receptors (Mody 2001; Olsen and
Sieghart 2009). GABAA receptor δ subunits are so far found to be exclusively present in
extrasynaptic sites (Farrant and Nusser 2005). The α4 subunit has relatively low expression in
the CNS (Wisden et al. 1992) and α4βδ GABAA receptors are exclusively extrasynaptic (Wei
et al. 2003), whereas α4βγ2 may be localized at the synapse, as well as extrasynaptically (Hsu
et al. 2003; Liang et al. 2006). Given this distinction, the study of synaptic vs. extrasynaptic
GABAA receptors and the effect of ethanol on these receptors is essential to elucidate the
mechanism involved in development of ethanol actions including tolerance and dependence.
Additionally, the role of various subunits in GABAA receptor-mediated actions has been
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studied by recombinant expression studies in vitro and by genetically modified mouse models
and pharmacologic modulators in vivo. In this review, we address the role of various subunits
in ethanol actions by referring to various subunit-containing receptors. For example, the α1
subunit-containing receptors will be referred to as α1-GABAA receptors.
Acute effects of ethanol on GABAA receptors
Behavioral evidence of GABAergic involvement in ethanol effects
Alcohol consumption produces many well-known behavioral effects including anxiolysis,
impaired motor coordination, impaired cognitive function, sedation, hypnosis, anticonvulsant,
and pro-aggressive action. Strikingly, many of these behavioral effects of ethanol overlap with
the effects of GABAA receptor agonists and can be altered by GABAA receptor modifiers.
GABAA receptor agonists (benzodiazepines, muscimol) increase ethanol responses whereas
inverse agonists and antagonists (Ro15-4513, picrotoxin, bicuculline) decrease ethanol
responses (see Grobin et al. 1998 for review).
Genetically modified mouse models such as transgenics and global knockouts have increased
our understanding of GABAA receptor involvement in behavioral ethanol actions (see Boehm
et al. 2006, 2004b; Crabbe et al. 2006 for more detailed reviews). For instance, the locomotor-
stimulant effects of ethanol appear to be modulated by α1-GABAA receptors. The α1-
GABAA receptor knockout mice have increased ethanol-induced activity (Blednov et al.
2003b; June et al. 2007; Kralic et al. 2003). Ethanol’s sedative-hypnotic effects may also
involve interactions with α1-GABAA receptors since male α1-GABAA receptor knockout mice
have reduced loss of righting reflex duration (Blednov et al. 2003a). However, this effect was
not observed in other studies (Kralic et al. 2003), possibly due to variation in genetic
background of the strains used to create separate knockout mouse lines. Further, α2-GABAA
receptors are implicated in the sedative-hypnotic effects of ethanol, as shown by reduced
ethanol-induced loss of righting reflex in α2- GABAA receptor knockout animals (Boehm et
al. 2004b). Studies using benzodiazepine-insensitive histidine101 to arginine (H101R) knockin
mice have also indicated a role for α2-GABAA receptors in ethanol’s sedative-hypnotic effects.
The combined effect of subthreshold doses of diazepam and ethanol resulted in a loss of righting
reflex in α1-, α3-, and α5-, but not α2- (H101R) GABAA receptor knockin mice (Tauber et al.
2003). Additionally, β2-GABAA receptors may also play a role in ethanol’s sedative-hypnotic
effects, as male β2-GABAA receptor knockout mice displayed reduced loss of righting reflex
duration compared to controls (Blednov et al. 2003a). Surprisingly, given the similarity of
benzodiazepine and ethanol effects on anxiety, the α1-, α2-, α4-, α5-, γ2L-, and δ-GABAA
receptor knockout mice did not display changes in ethanol-induced anxiolysis (Boehm et al.
2004b; Chandra et al. 2008; Homanics et al. 1999a; Kralic et al. 2003; Mihalek et al. 2001).
Further studies are clearly needed to elucidate whether specific GABAergic receptor subtypes
mediate the anxiolytic effects of ethanol.
Several studies suggest that GABAA receptors may be involved in ethanol preference. α1-
GABAA receptor knockouts consumed less ethanol in a two-bottle choice drinking study, but
also showed reduced saccharin preference compared to wildtype mice (Blednov et al. 2003b;
June et al. 2007). In studies of ethanol reinforcement, α1-GABAA receptor knockouts exhibited
reduced operant responding for ethanol, although this was also accompanied by a reduced
responding for sucrose (June et al. 2007). In contrast, α5- and δ-GABAA receptor knockouts
showed reduced ethanol preference with no changes in saccharin preference (Boehm et al.
2004b; Mihalek et al. 2001; Stephens et al. 2005). Additionally, a recent study utilizing viral
vectors (Rewal et al. 2009) demonstrates that reduction of α4-GABAA receptor subunits in the
nucleus accumbens shell by RNA interference decreases ethanol consumption and preference.
Further studies in other brain areas as well as studies targeting other subunits will be of great
interest. Remarkably, many other ethanol-induced behaviors remain unaltered in mice with
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genetically modified GABAA receptors. For instance, the δ-GABAA receptors do not appear
necessary for the discriminative stimulus effects of ethanol or substitution by barbiturates,
benzodiazepines, and neuroactive steroids in knockout mice (Shannon et al. 2004). One caveat
to these studies is that observed effects or lack of effects may be due to compensatory changes
that are sometimes observed in knockout models and should be taken into consideration.
Nonetheless, these studies implicate GABAA receptor subtypes in some behavioral actions of
ethanol.
Pharmacologic dissection of GABAA receptors in ethanol action has also identified a potential
role for GABAA receptor subtypes in ethanol reinforcement. For instance, α1-GABAA
receptors in the ventral pallidum are involved in the reinforcing properties of ethanol (Harvey
et al. 2002). Systemic administration or infusion into the ventral pallidum of an α1 selective
mixed benzodiazepine agonist–antagonist, 3-propoxy-β-carboline hydrochloride, reduces
ethanol-maintained responding in ethanol-preferring rats. α1-GABAA receptors have also been
implicated in ethanol-related heightened aggressive behavior (de Almeida et al. 2004).
Administration of the benzodiazepine antagonist flumazenil or the preferential α1 antagonist,
β-carboline-3-carboxylate-t-butyl ester, decreases ethanol-related aggression in mice trained
to self-administer ethanol. The α5-GABAA receptors appear to play a role in the rewarding,
motor-impairing, and sedative effects of ethanol in rats, since the selective inverse-agonist
RY023 impacts these actions (Cook et al. 2005). Furthermore, interactions between ethanol
and benzodiazepines increase spatial memory deficits in animals (Takiguchi et al. 2006) and
humans (Simpson and Rush 2002) implicating γ2-GABAA receptors in spatial memory
impairment. The development of more subtype specific/selective compounds will aid in further
elucidating the role of specific GABAA receptor subtypes in ethanol action. Newer, more
selective compounds such as L-838,417 (which has selectivity for α2-/α3-/α5-GABAA
receptors) will be particularly useful in identifying the role of specific receptor subtypes (see
Atack 2003 for review).
The discriminative stimulus paradigm has been used as an in vivo assay of receptor-mediated
activity and can be a useful tool to define the neurotransmitter systems that underlie the
behavioral effects of a given dose and class of drugs (Holtzman 1990). Positive modulators of
GABAA receptors, like benzodiazepines, barbiturates, and certain neuroactive steroids, all
produce ethanol-like discriminative stimulus effects in water vs. ethanol discrimination in
pigeons, mice, rats, gerbils, and cynomolgus monkeys (Grant 1999; Grant et al. 1996, 2008a;
Shelton and Grant 2002). Recent studies have aimed to understand the contribution of different
GABAA receptor subtypes to the discriminative stimulus properties of ethanol. Studies in non-
human primates show that ethanol and zolpidem share similar discriminative stimulus effects
suggesting that ethanol’s sedative-hypnotic actions may involve α1-GABAA receptors (Helms
et al. 2008). However, zolpidem antagonism by Ro15-4513 may involve additional zolpidem-
sensitive α2-/α3-/α5-GABAA receptor subtypes (Helms et al. 2008). In contrast, Platt and
collaborators (Platt et al. 2005) reported a prominent role for the α5- but not the α1-GABAA
receptors in the discriminative stimulus effects of ethanol and the ethanol-like effects of
benzodiazepines in squirrel monkeys. However, the ethanol-like discriminative stimulus
effects are complex. For instance, the discriminative stimulus effects of low doses of ethanol
(1.0 g/kg) are predominantly mediated by GABAA receptor positive modulation, while higher
doses (2.0 g/kg) require other systems such as N-methyl-D-aspartate (NMDA) receptors (Grant
1999). Indeed, ethanol’s discriminative stimulus effects are mediated by interactions of
GABAA, NMDA, and metabotropic glutamate receptor subtype 5 (mGluR5), located in
specific limbic brain regions such as nucleus accumbens core and amygdala (Besheer et al.
2003; Besheer and Hodge 2005; Hodge and Cox 1998).
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Direct effects on GABAA receptor subtypes
Low dose effects of ethanol (≤30 mM) on tonic inhibition—While much work has
shown that ethanol enhances GABAA receptor potentiation, the exact mechanism of ethanol
actions on these receptors remains unclear. Recent work has addressed the contribution of
specific GABAA receptor subtypes in distinct cellular localizations at ethanol concentrations
typically found in social settings (3–30 mM). Several groups have shown that ethanol enhances
the inhibition of α4/6βδ-GABAA receptors (found extra-synaptically), whereas receptors
containing a γ2 subunit (found synaptically) are significantly less sensitive to the ethanol
enhancement of GABAergic responses (Sundstrom-Poromaa et al. 2002; Wallner et al. 2003;
Wei et al. 2004). Typically, δ-GABAA receptors are found extrasynaptically and are commonly
associated with α4/α6 subunits (Jones et al. 1997; Sur et al. 1999; Wei et al. 2003). Additionally,
these receptors have a greater affinity for GABA (Brown et al. 2002; Wallner et al. 2003) and
knockout models display substantially reduced/absent tonic inhibition (Brickley et al. 2001;
Chandra et al. 2006; Stell et al. 2003). Importantly, δ-GABAA receptor knockout mice also
have reduced/ablated enhancement of tonic current by ethanol (Glykys et al. 2007). Therefore,
it is likely that ethanol actions on α4/6βδ-GABAA receptors involve the modulation of tonic
inhibition in vivo.
In parallel, the ‘ethanol antagonist’ Ro15-4513 has been shown to bind with high affinity to
δ-GABAA receptors that are activated by low concentrations of ethanol (Hanchar et al.
2006). Ethanol-induced potentiation of α4βδ-GABAA receptors by low ethanol concentrations
is blocked by Ro15-4513 (Wallner et al. 2006). Changes in tonic inhibition may alter ethanol-
related behavioral responses. Hanchar et al. (2005) noted that a naturally occurring mutation
found in outbred Sprague-Dawley rats (arginine100 to glutamine, R100Q; also found in
Sardinian non-preferring rats and ethanol non-tolerant rats) substantially increases the
sensitivity of α6β3δ-GABAA receptors to ethanol. Importantly, rats with the naturally
occurring mutation exhibit greater enhancement of tonic inhibition in cerebellar granule cells
as well as greater motor impairment due to ethanol. Moreover, it now appears that tonic current
is not solely dependent on the presence of α4δ- or α6δ-GABAA receptors. α1δ-GABAA
receptors also mediate ethanol-induced increases in tonic inhibition in hippocampal
interneurons in α4-GABAA receptor knockout mice (Glykys et al. 2007). Further studies of
ethanol actions on these receptors are needed.
High dose effects of ethanol (>30 mM) on tonic inhibition—While the previously
described studies have indicated a major role of ethanol potentiation of GABA inhibition at
α4/6βδ extrasynaptic receptors, these observations are controversial. In a recent study by
Borghese et al. (2006a), rat and human α4β3δ-GABAA subunits expressed in oocytes, α4β3δ
subunits stably transfected in fibroblasts, and slice recordings conducted in dentate granule
cells all failed to exhibit enhanced GABAA receptor potentiation by low doses of ethanol.
Further, effects of lower doses of ethanol (30 mM or less) are not observed in cerebellar granule
cells (Casagrande et al. 2007; Yamashita et al. 2006) or ventrobasal thalamic neurons (Jia et
al. 2008a) and dentate gyrus granule cells that express α4β2δ receptors (Liang et al. 2008).
However, the latter study did observe some detectable effects at 10 mM ethanol. One possibility
may be the orientation of receptor subunits within the GABAA receptor pentamer. However,
Kaur et al. (2009) have shown that 30 mM ethanol did not display potentiation in concatenated
α1β3δ receptors. In agreement with the lack of a low dose effect, autoradiographic experiments
also suggest that Ro15-4513 binding is not altered by low concentrations of ethanol (Korpi et
al. 2007). Additionally, the naturally occurring R100Q mutation in α6-GABAA receptors does
not increase ethanol sensitivity at extrasynaptic receptors in outbred rats or in ethanol non-
tolerant rats as described above (Botta et al. 2007a; Valenzuela et al. 2005). In agreement with
the lack of a low dose effect, α4- and δ-GABAA receptor knockout mice do not show any major
changes in acute ethanol-related behaviors (Chandra et al. 2008; Mihalek et al. 2001).
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Nonetheless, electrophysiologic studies utilizing α4-GABAA receptor subunit knockout mice
did not show ethanol-enhanced tonic inhibition compared to controls at 50 mM (Jia et al.
2008a; Liang et al. 2008). Many of these studies assessing low dose ethanol effects on
extrasynaptic receptors and tonic inhibition are summarized in Table 1.
The discrepancies in ethanol actions observed across various laboratories may indicate very
specific requirements for low dose effects of ethanol on extrasynaptic GABAA receptors. It is
also possible that presynaptic ethanol actions may play a role. Recent studies suggest that
increased firing onto cerebellar granule cells increases extrasynaptically available GABA
(Botta et al. 2007b; Carta et al. 2004; Valenzuela et al. 2005) that may contribute to changes
in tonic inhibition. Other mechanisms may include increases in endogenous modulators that
are particularly potent at extrasynaptic GABAA receptors. Ethanol increases GABAergic
neuroactive steroids in slice preparations (see ‘Ethanol-induced elevation of neuroactive
steroids’). Ethanol also increases taurine (De Witte et al. 1994), which has been shown to
enhance tonic inhibition at low concentrations (Jia et al. 2008b). The possibility exists that
other unknown chemicals are also released by ethanol. Alternatively, it is possible that the
intracellular milieu of different preparations, including second messengers, kinases and
phosphatases, may contribute to ethanol actions. Indeed, recent work by Choi et al. (2008)
using knockout mice and stably transfected cells has shown that PKCδ activity may be required
for ethanol enhancement of extrasynaptic GABAA receptor responses and this requirement
may explain the lack of consistent effects in prior studies. Irrespective of the low ethanol dose
discrepancy, it is clear that ethanol does enhance tonic inhibition, and that low dose actions of
ethanol may have multiple mechanisms. Further studies are needed to clarify these
discrepancies.
High dose effects of ethanol (>30 mM) on phasic inhibition—GABAA receptor
subtypes associated with phasic inhibition are modulated by higher doses of ethanol. Using
chimeric receptors, Mihic et al. (1997) identified a 45-amino-acid region spanning the second
and third transmembrane domains required for the direct enhancement of glycine receptors by
ethanol and volatile anesthetics. Moreover, the mutation of two residues (serine270 and
alanine291) produces receptors insensitive to ethanol-induced potentiation. Interestingly, the
volume of this putative ethanol ‘binding pocket’ dictates receptor sensitivity to ethanol (Wick
et al. 1998; Ye et al. 1998). GABAA receptors possessing the serine270 mutation have altered
receptor gating and are hypersensitive to GABA (Ueno et al. 2000). Moreover, knockin mice
with the serine270 to histidine (S270H) mutation show marked abnormal behaviors, premature
mortality, and prolonged miniature inhibitory post-synaptic currents (mIPSCs) (Homanics et
al. 2005). Nonetheless, the mutation of leucine277 to alanine (L277A) in combination with
S270H restored GABA sensitivity to near normal affinity while retaining ethanol and volatile
anesthetic insensitivity in vitro (Borghese et al. 2006b). Importantly, gene knockin mice with
both mutations show decreased sensitivity to ethanol potentiation (80 mM) and recover more
quickly from ethanol’s motor ataxic effects, but do not differ on many other ethanol-related
behaviors (Werner et al. 2006). These studies implicate a molecular site of action on
GABAA receptors found synaptically that contributes to high dose ethanol action.
A membrane-spanning region of the β3-GABAA receptor subunit is also implicated in
GABAA receptor responses to higher amounts of ethanol. Work by Wallner et al. (2006) has
indicated that while Ro15-4513 blocked ethanol-induced potentiation at low doses, higher
concentrations of ethanol still enhanced GABAA receptor function in the presence of
Ro15-4513. Mutations in equivalent positions in β1-GABAA receptors also modulate ethanol
responses like intravenous anesthetic GABAA receptor modulators etomidate and propofol in
β3-GABAA receptors (Jurd et al. 2003; Mihic et al. 1997). This evidence supports the notion
that ethanol and Ro15-4513 may bind to the same site on GABAA receptors at low ethanol
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concentrations whereas a second ethanol-binding site involving α and β subunits may be
responsible for ethanol responses at higher concentrations.
Overall, a considerable amount of evidence continues to accumulate that suggests GABAA
receptors may directly modulate some ethanol effects. More so, it is becoming apparent that
different GABAA receptor subtypes not only respond to different ethanol concentrations but
their cellular localization may contribute to various ethanol-related responses.
Indirect ethanol effects on GABAA receptor subtypes
Ethanol-mediated post-translational modification of GABAA receptors—Protein
phosphorylation regulates GABAA receptor function under numerous physiologic conditions
(Brandon et al. 2000; Kellenberger et al. 1992; Krishek et al. 1994; Kumar et al. 2005;
Leidenheimer et al. 1992; Poisbeau et al. 1999), including alcoholism and epilepsy (Kumar et
al. 2006; Niimura et al. 2005; Rakhade et al. 2008). Several protein kinases, including PKC
and PKA, have consensus sites on GABAA receptor subunits and can phosphorylate these
subunits (Brandon et al. 2000; McDonald and Moss 1997). Phosphorylation of GABAA
receptor subunits can modify GABA binding to its receptor (Oh et al. 1999), channel
conductance, and possibly internalization (Moss and Smart 2001). Additionally, studies using
genetically modified mice clearly demonstrate that the pharmacological and behavioral effects
of ethanol are partially mediated by PKC activity (Choi et al. 2008; Harris et al. 1995; Hodge
et al. 1999; Proctor et al. 2003).
PKC phosphorylation: A large volume of recent work has focused on the role of PKC as a
regulator of GABAA receptor function following ethanol exposure. Various PKC isoforms
associate with GABAA receptors and therefore may alter receptor subunit phosphorylation and
function. PKCβ associates with GABAA receptor β subunit and alters GABAA receptor
phosphorylation and function (Connolly et al. 1999). PKCγ co-immunoprecipitates with α1-
and α4-GABAA receptors in the cerebral cortex (Kumar et al. 2002) and PKCε co-localizes
with various GABAA receptor subunits across the brain (Olive and Hodge 2000). Similarly,
PKCδ alters the function of extrasynaptic GABAA receptors (Choi et al. 2008). Despite the
existence of several isoforms of PKC, genetic deletion of PKCγ, PKCε, and PKCδ has clearly
demonstrated that these isoforms are major players in ethanol-mediated modulation of
GABAA receptor function both in vitro and in vivo. For example, PKCγ knockout mice show
reduced sensitivity to the anxiolytic effects of both intoxicating and sedative doses of ethanol
(Bowers et al. 2001), while PKCδ knockout mice are insensitive to the ataxic effects of ethanol
(Choi et al. 2008) and PKCε knockout mice show increased ethanol sensitivity (Hodge et al.
1999). Furthermore, mice lacking the gene for PKCγ show a significant reduction in ethanol
potentiation of GABA responses compared to responses in wildtype mice (Harris et al. 1995;
Proctor et al. 2003). In contrast, ethanol and flunitrazepam potentiation of muscimol-stimulated
chloride (Cl−) uptake is greater in microsacs from PKCε knockout mice compared to wildtype
controls (Hodge et al. 1999). Therefore, it appears that the ε and γ isoforms of PKC have
opposing influences on ethanol enhancement of GABAA receptor function. PKCδ plays a
critical role in ethanol effects on extrasynaptic GABAA receptors. PKCδ knockout mice display
a reduction in ethanol-induced ataxia as well as ethanol-mediated tonic current in thalamic and
dentate granule cell neurons (Choi et al. 2008). Taken together, it is likely that various PKC
isoforms mediate phosphorylation of GABAA receptors and/or associated proteins and
modulate GABAA receptor function following ethanol exposure.
Acute systemic ethanol administration directly alters PKC activity and expression in the brain
(Kumar et al. 2006). However, ethanol administration to rats (2 g/kg) differentially alters
PKCβ, γ, and ε expression and translocation to the P2 fraction of rat cerebral cortex (Kumar
et al. 2006). PKCβ and PKCε expression in subcellular fractions exhibited responses to ethanol
Kumar et al. Page 7













that likely represent increased synthesis and translocation, since increased levels of these
kinases in the P2 fraction would require translocation of the enzyme. On the other hand,
PKCγ expression and translocation to the P2 fraction of cortex are reduced by ethanol. These
effects were associated with alterations in phosphorylation of both GABAA and NMDA
receptors and/or associated proteins. Hence, ethanol differentially alters PKC expression in an
isoform-specific manner and these effects are likely to contribute to GABAergic (and
glutamatergic) actions of ethanol.
Phosphorylation of various GABAA receptor subunits can alter receptor function without
altering receptor expression. We have shown that acute ethanol administration (2 g/kg)
decreased serine phosphorylation of GABAA receptor β subunits without altering the
expression of these subunits in the P2 fraction of rat cerebral cortex (Kumar et al. 2006). This
suggests that ethanol may alter the phosphorylation state of receptors to alter GABAA receptor
function and these effects may contribute to ethanol actions. This is consistent with the
observation of increased GABAA receptor function following ethanol exposure. Likewise,
reduced phosphorylation of the GABAA receptor γ2 subunit enhances the action of ethanol
(Qi et al. 2007). PKCε phosphorylates the GABAA receptor γ2 subunit at serine327 in vitro
and γ2 serine327 phosphorylation is reduced in mice lacking PKCε. In addition, exposure to
ethanol (4 g/kg) for 1 h increases γ2 serine327 phosphorylation in the cerebellum of wildtype
mice, but not PKCε knockout mice and this leads to reduced GABAA receptor function in
cerebellar microsacs (Qi et al. 2007). Finally, phosphorylation at serine327 on GABAA
receptor γ2 subunits is required for PKCε-mediated modulation of GABAA receptor function
(Qi et al. 2007). Further studies investigating post-translational modification of these receptors
at PKC phosphorylation sites by specific PKC isoforms will lead to a better understanding of
PKC-mediated effects of ethanol on GABAA receptors.
PKA phosphorylation: Accumulating evidence indicates that the cyclic adenosine
monophosphate (cAMP)-dependent kinase PKA is involved in the neurobiological responses
to ethanol. PKA is a tetramer composed of a regulatory homodimer and two catalytic subunits.
PKA activation occurs when cAMP binds to the regulatory subunits of the PKA complex,
liberating the catalytically active subunits, which diffuse throughout the cell and phosphorylate
nearby proteins. Ethanol stimulates cAMP signaling through activation of adenosine A2a
receptors. Since A2a receptors are coupled to stimulatory G proteins, this increases levels of
intracellular cAMP followed by stimulation of PKA (see Diamond and Gordon 1994 for
review). Recently, we have found that acute ethanol exposure increases the expression of PKA
regulatory RIIα and RIIβ subunits in the membrane fraction of rat cerebral cortex and also
alters GABAA receptor expression (Kumar et al. 2008). Therefore, it appears that ethanol alters
PKA expression in a subunit specific manner and may affect GABAA receptor expression.
Recent pharmacological and genetic studies have provided additional evidence for the
importance of the cAMP/PKA system in regulating the neurobiological responses to ethanol.
PKA inhibition (using micro-infusions of the PKA inhibitor Rp diastereomer of adenosine 3′,
5′-cyclic mono-phosphorothioate, Rp-cAMPS) in the central amygdala prevents the
development of anxiety in rats during ethanol withdrawal (Pandey et al. 2003). Other studies
have shown that the PKA signaling pathway plays an important role in the modulation of
several ethanol-induced behavioral actions such as loss of righting reflex (Maas et al. 2005;
Thiele et al. 2000). For example, PKA regulatory RIIβ subunit mutant mice, which exhibit
lower total cAMP-stimulated PKA activity, are less sensitive to the sedative-hypnotic effects
of ethanol as assessed by the loss of righting reflex test (Lai et al. 2007). Furthermore, in
vivo studies show that mutant Drosophila lacking production of the RII subunit of PKA are
resistant to the intoxicating effects of ethanol (Park et al. 2000). In addition, PKA has been
shown to alter GABAA receptor function. For example, PKA activation causes a decrease in
GABA-activated currents in cultured cerebellar granule cells, hippocampal pyramidal cells,
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and spinal cord neurons (Moss et al. 1992; Poisbeau et al. 1999; Porter et al. 1990; Robello et
al. 1993). Taken together, it is clear that PKA also plays a role in ethanol-mediated behavior
and may influence GABAA receptor function.
Phosphorylation by fyn and tyrosine kinase: Recent studies have shown that fyn kinase is
involved in ethanol-induced changes in GABAA receptor function. For example, over-
expression of fyn kinase reduces sedative-hypnotic sensitivity to ethanol (Boehm et al.
2004a). Furthermore, fyn kinase knockout mice are less sensitive to the sedative-hypnotic
effects of etomidate (an intravenous anesthetic, selective for β2- and/or β3-GABAA receptors;
see Jurd et al. 2003) suggesting that fyn kinase alters GABAA receptor function by acting on
GABAA receptor β2 and β3 subunits (Boehm et al. 2004c). Similarly, in vitro and in vivo
studies have implicated tyrosine kinase in ethanol-mediated alterations of GABAA receptor
function. Ethanol exposure increases tyrosine kinase phosphorylation of the GABAA receptor
subunits α1, β2, and γ2 in mouse cultured cortical neurons (Marutha Ravindran and Ticku
2006) and rat cerebral cortex (Marutha Ravindran et al. 2007). In addition, tyrosine kinase
phosphorylation of GABAA receptor γ2 subunit regulates GABAA receptor surface expression
and function (Kittler et al. 2008). Hence, it appears that multiple kinases are involved in
ethanol-mediated alteration in GABAA receptor function. Therefore, studies of the interactions
of GABAA receptors with these kinases will lead to a better understanding of ethanol actions
on GABAA receptors.
Dephosphorylation: The phosphorylation state of a given protein is governed by the balance
between protein kinases that transfer phosphate from adenosine triphosphate (ATP) to the
protein (phosphorylation) and protein phosphatase that catalyzes the reverse reaction
(dephosphorylation). It is now widely acknowledged that the regulation of protein
phosphorylation requires coordinated control of both kinases and phosphatases. The effect of
ethanol exposure on protein phosphatase expression and activity is still not known. However,
phosphatase inhibitors alter the function of GABAA receptors by reducing GABAA receptor
rundown (Huang and Dillon 1998). In addition, blockade of phosphatase activity during
preparation of cerebral cortical synaptoneurosomes decreases muscimol-induced Cl− uptake
(Kumar et al. 2005). Hence, the balance between phosphatase and kinase activity is important
for GABAA receptor function. Further studies on the effects of ethanol on protein phosphatase
activity are warranted.
Ethanol-induced elevation of neuroactive steroids—Neuroactive steroids are
endogenous neuromodulators, synthesized de novo in the brain as well as adrenal glands,
ovaries, and testes (see Biggio and Purdy 2001 for review). Among these compounds, the 3α,
5α- and 3α,5β-reduced metabolites of progesterone (Majewska et al. 1986; Morrow et al.
1987), deoxycorticosterone (Majewska et al. 1986; Morrow et al. 1987),
dihydroepiandrosterone (DHEA) (Frye et al. 1996; Kaminski et al. 2005; Park-Chung et al.
1999), and testosterone (Kaminski et al. 2005, 2006) enhance GABAergic neurotransmission.
Their systemic administration induces anxiolytic, anticonvulsant, sedative-hypnotic, and
cognitive-impairing effects, similar to other GABAA receptor positive modulators and ethanol
(see Morrow et al. 2006 for review).
Systemic administration of moderate doses of ethanol (1–2.5 g/kg) increases brain and plasma
levels of (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP), (3α,5α)-3,21-
dihydroxypregnan-20-one (3α,5α-THDOC), and their precursors in rodents (Barbaccia et al.
1999; Gabriel et al. 2004; Khisti et al. 2005; Korneyev et al. 1993; Morrow et al. 1998; 1999;
O’Dell et al. 2004; Serra et al. 2003; VanDoren et al. 2000). The ethanol-induced increase in
neuroactive steroids is mediated by the hypothalamic–pituitary–adrenal (HPA) axis, since it is
no longer observed immediately following adrenalectomy/gonadectomy in rats (Khisti et al.
2003; O’Dell et al. 2004; Porcu et al. 2004). However, ethanol can increase neuroactive steroids
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in hippocampal slices from both intact (Sanna et al. 2004) and adrenalectomized/
gonadectomized rats (Follesa et al. 2006) and this finding is associated with an enhancement
of GABAergic inhibition that can be blocked by the neuroactive steroid biosynthesis inhibitor
finasteride (Sanna et al. 2004).
Ethanol-induced elevations in neuroactive steroids reach physiologically relevant
concentrations that are capable of enhancing GABAergic transmission. A large body of
evidence from multiple laboratories suggests that ethanol-induced elevations of GABAergic
neuroactive steroids contribute to several behavioral effects of ethanol in rodents. Neuroactive
steroids have been shown to modulate ethanol’s anticonvulsant effects (VanDoren et al.
2000), sedation (Khisti et al. 2003), impairment of spatial memory (Matthews et al. 2002;
Morrow et al. 2001), anxiolytic-like (Hirani et al. 2005), antidepressant-like (Hirani et al.
2002), and pro-aggressive (Fish et al. 2001) actions. Most of these behavioral responses are
prevented by pretreatment with finasteride and/or by prior adrenalectomy (Hirani et al. 2002;
2005; VanDoren et al. 2000). The sedative-hypnotic effect of ethanol is partially blocked by
adrenalectomy (Khisti et al. 2003). Importantly, administration of 5α-dihydroprogesterone, the
immediate precursor of 3α,5α-THP, to adrenalectomized rats restores effects of ethanol,
showing that brain synthesis of neuroactive steroids can modulate effects of ethanol (Khisti et
al. 2003). However, neuroactive steroids do not appear to influence the motor incoordinating
effects of ethanol, since neither finasteride administration nor adrenalectomy diminish these
actions (Khisti et al. 2004). Taken together, these studies suggest that elevations in neuroactive
steroids influence many of the GABAergic effects of ethanol in vivo and contribute to
sensitivity to the behavioral effects of ethanol.
Acute application of ethanol (50 and 100 mM) to freshly isolated rat hippocampal slices
increases tissue levels of 3α,5α-THP (Sanna et al. 2004). In addition, application of
progesterone (the 3α,5α-THP precursor), CB34 (a peripheral benzodiazepine receptor agonist),
or γ-hydroxybutyric acid, all of which promote steroidogenesis, also increases tissue levels of
3α,5α-THP. The increase in 3α,5α-THP induced by ethanol, progesterone, CB34, or γ-
hydroxybutyric acid is prevented by pretreatment with the neuroactive steroid inhibitor
finasteride. Furthermore, this increase in 3α,5α-THP levels is capable of potentiating
GABAA receptor function, measured by recordings of spontaneous mIPSCs. Ethanol increases
mIPSC amplitude and frequency in a time-and concentration-dependent manner: the effect is
observed within the first 3 min, then it is reduced at 10 min and reappears after 30 min. In
contrast, the decay time is increased 30 min after ethanol exposure. However, pretreatment
with finasteride inhibits the increase in mIPSC amplitude and decay time constant at 30 min,
but has no effect on mIPSC frequency, suggesting that the presynaptic action of ethanol is not
mediated by an increase in neuroactive steroid content (Sanna et al. 2004).
Presynaptic GABA release—Many GABAergic effects of ethanol likely result from the
ability of ethanol to enhance presynaptic GABA release in spinal cord (Ziskind-Conhaim et
al. 2003), amygdala (Roberto et al. 2003; 2004), hippocampus (Ariwodola and Weiner 2004),
and cerebellum (Criswell and Breese 2005) An ethanol-induced increase in GABA release
would be expected to modulate all subtypes of GABAA receptors and could clearly contribute
to the behavioral effects of ethanol mediated by GABAA receptors in brain. This effect of
ethanol exhibits regional and neuronal specificity (Criswell et al. 2008), suggesting that it may
contribute to heterogeneity of ethanol interactions. Moreover, chronic exposure to GABA alters
GABAA receptor α1 subunit expression (Calkin and Barnes 1994; Montpied et al. 1991a),
internalization (Tehrani and Barnes 1997), and decreases GABAA receptor-mediated
inhibition (Roca et al. 1990), similar to the effects of ethanol on GABAA receptor α1 subunit
expression (Kumar et al. 2003). Thus, ethanol-induced increases in GABA release likely
contribute to ethanol-induced changes in GABAA receptor surface expression that appear to
be involved in ethanol tolerance, dependence, and withdrawal.
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Chronic administration of ethanol
Behavioral effects
Chronic ethanol exposure results in CNS hyperexcitability during and following withdrawal
from ethanol exposure. These effects include a heightened risk for seizures, increased anxiety,
hyperalgesia, and disruptions in sleep states. While the exact molecular mechanisms
attributable to each of these effects are not fully understood, an overwhelming amount of
evidence points to GABAA receptor involvement (see Grobin et al. 1998 for review).
Genetically modified mouse models have contributed to our understanding of the relationship
between GABAA receptor subtype expression and CNS hyperexcitability. Recent work in the
ethanol-insensitive (S270H, L277A) α1-GABAA receptor knockin animals indicates that α1
subunits play a significant role in CNS excitability. Male knockin mice display enhanced
ethanol withdrawal-related handling-induced convulsions (HICs) (Werner et al. 2009).
Additionally, a number of mortalities were observed in the knockin mice that were attributable
to seizure severity, whereas mortalities were not observed following ethanol exposure in
control mice. However, knockin mice exhibited spontaneous seizures that may have kindled
ethanol-withdrawal seizure susceptibility. Interestingly, α1-GABAA receptor knockout mice
had increased seizure susceptibility to bicuculline as well as more severe seizures and death
(Kralic et al. 2002a). In other studies, α1-GABAA receptor knockout mice did not differ in
withdrawal-related HICs, but these mice consumed less ethanol prior to withdrawal than
wildtype control mice, possibly masking a difference between mouse lines (Blednov et al.
2003b). Studies have also assessed the role of β subunits in ethanol withdrawal seizure severity.
β2-GABAA receptor knockout mice had increased HICs after chronic ethanol (Blednov et al.
2003b); however, knockouts had higher ethanol intake than controls. In other studies, β3
asparagine265 to methionine (N265M)-GABAA receptor knockin mice had enhanced
withdrawal following chronic ethanol exposure (Sanchis-Segura et al. 2007). Withdrawal from
acute high doses of ethanol has also been used to assess the role of specific GABAA receptor
subtypes. The expression of γ2 subunits, which are involved in phasic inhibition, has also been
thought to play a role. Work has shown that allelic variation in gabrg2, the gene encoding for
the γ2 subunit, was correlated with withdrawal-related behavior (Hood and Buck 2000).
However, γ2L-GABAA receptor knockouts had similar withdrawal-related HICs (Homanics
et al. 1999a). In studies of subunits involved in tonic inhibition, δ-GABAA receptor knockout
mice displayed decreased ethanol withdrawal HICs than controls; however, this effect was
dependent on background strain of the mice (Mihalek et al. 2001). Interestingly, studies in
α6-GABAA receptor knockout mice (which pairs with δ in the cerebellum) did not differ in
ethanol withdrawal-related HICs (Homanics et al. 1997). Finally, withdrawal from acute high
doses of ethanol has also been used to assess the role of specific GABAA receptor subtypes.
For instance, γ2-GABAA receptor transgenic mice did not differ from controls (Wick et al.
2000) in sensitivity to acute withdrawal HICs (Boehm et al. 2004b).
Apart from genetically modified mouse models, other studies have also implicated GABAA
receptors in ethanol dependence. For instance, pentylenetetrazole-kindled animals displayed
ethanol withdrawal behavior similar to animals exposed to repeated cycles of ethanol
withdrawal (Davidson et al. 1999). Moreover, animals subjected to repeated withdrawals
exhibit faster pentylenetetrazole-kindled seizure activity compared to controls and animals
experiencing only a single ethanol withdrawal (Ripley et al. 2002). Additionally, while
lorazepam could decrease HIC severity in repeated withdrawals, this intervention led to an
exacerbated final withdrawal compared to animals that did not receive lorazepam during
multiple withdrawals from ethanol (Becker and Veatch 2002). These results hint that this
interactive effect between benzodiazepines and ethanol may involve GABAA receptors.
Studies with benzodiazepines have also implicated GABAA receptors in ethanol withdrawal-
related hyper-algesic effects. Diazepam reversed ethanol withdrawal hyperalgesia, but this
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effect could not be reversed by flumazenil (Gatch 1999). Studies have also shown that
flumazenil reduces seizure severity (Buck et al. 1991b) and reverses the anxiogenic-like effects
(Moy et al. 1997) associated with ethanol withdrawal. While known as a benzodiazepine
antagonist, flumazenil has also been shown to have some partial agonist activity (see File and
Pellow 1986 for review) and the effects of partial agonists are enhanced following chronic
ethanol exposure (Liang et al. 2004). These studies, as well as those involving genetically
modified mice, suggest that specific GABAA receptor subtypes and/or regulation of these
receptors contribute to ethanol dependence and further implicate GABAA receptors as potential
therapeutic targets for treating alcoholism.
Functional adaptations
Prolonged ethanol consumption and repeated ethanol withdrawals produce many adaptations
of GABAA receptor function (Table 2). For instance, ethanol exposures result in the
development of tolerance to many of the GABAergic effects of ethanol including the sedative,
motor incoordinating, and acute cognitive-impairing effects of ethanol (Le et al. 1986;Silvers
et al. 2003c). Withdrawal from ethanol produces marked increases in CNS excitability that
form a criterion for ethanol dependence (Becker et al. 1997;Devaud et al. 1996;McCown and
Breese 1990;Moy et al. 2000). Substantial evidence suggests that these behavioral and neural
adaptations involve marked alterations in the pharmacological properties of GABAA receptors
(Table 2).
Alterations in GABAA receptor subunit expression, localization, and trafficking
The development of ethanol dependence is associated with alterations in many of the functional
properties of GABAA receptors throughout the brain which is attributed to altered expression
or composition of GABAA receptors on the cell surface. Chronic ethanol administration
differentially alters the expression of distinct GABAA receptor subunit mRNA and peptide
levels in various brain regions (Table 3). The levels of GABAA receptor α1, α2, and α3 subunit
mRNA/peptides are reduced in the cerebral cortex while α4, β1, β2, β3, γ1, and γ2 subunit
mRNA/peptide levels are increased in cerebral cortex following chronic ethanol exposure.
Since GABAA receptor α1 subunits are the most abundant subunit in the cerebral cortex, the
reduction in the expression of this subunit is likely to have significant functional consequences.
GABAA receptor α4 subunit expression measured by immunohistochemical labeling in brain
slices is sparse across most brain regions except the thalamus, dentate gyrus, and striatum
(Bencsits et al. 1999;Chandra et al. 2006;Pirker et al. 2000). However, selective modulation
of α4 subunit expression in the hippocampus, using antisense oligonucleotides, has been shown
to significantly alter the functional properties of GABAA receptors and modulate steroid
withdrawal excitability (Moran et al. 1998;Smith et al. 1998). Therefore, despite the relatively
low expression of α4 subunit peptide, modulation of α4 subunit expression clearly influences
GABAA receptor function and GABA-mediated behaviors in vivo. Recombinant expression
and homologous gene deletion studies have shown that functional properties are regulated by
the subunit composition of GABAA receptors. For example, recombinant GABAA receptors
with α4β2γ2 subunits respond to GABA and benzodiazepine agonists with lower efficacy than
α1β2γ2 receptors (Whittemore et al. 1996). Moreover, homologous genetic deletion of α1
subunits dramatically alters the pharmacological properties of GABAA receptors, reducing the
potency and efficacy of GABA and of the benzodiazepine diazepam (Kralic et al. 2002a,b).
Hence, alterations in GABAA receptor subunit expression appear critically important in
regulation of GABAA receptor function following chronic ethanol administration.
The regulation of various GABAA receptor subunits by ethanol differs across brain regions
(Grobin et al. 2000). For example, chronic ethanol consumption for 14 days increases
GABAA receptor α4 subunit peptide expression in the cerebral cortex and the hypothalamus
(Devaud et al. 1997), decreases α4 subunit peptide levels in the amygdala and nucleus
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accumbens (Papadeas et al. 2001), and does not alter α4 subunit peptide levels in the
hippocampus or ventral tegmental area (Matthews et al. 1998; Papadeas et al. 2001). However,
repeated ethanol withdrawals or longer ethanol exposure increases α4 subunit peptide
expression in the hippocampus (Cagetti et al. 2003; Matthews et al. 1998) and these effects are
associated with alterations in the pharmacological responses of GABAA receptors to
benzodiazepine agonists and inverse agonists (Cagetti et al. 2003). Furthermore, in cerebellum,
α6 subunit mRNA and peptide levels are increased while α1 subunit peptide and mRNA are
decreased following chronic ethanol administration (Mhatre et al. 1993; Morrow et al. 1992).
Therefore, it is clear that adaptation in GABAA receptor subunits expression caused by chronic
ethanol administration is not universal across brain regions. The mechanisms that underlie
regional differences in the regulation of GABAA receptors by ethanol are unclear but may
involve mechanisms to be described in the following sections.
Alterations in synaptic localization of receptors—Given the important role of synaptic
vs. extrasynaptic GABAA receptors in acute ethanol effects, it is important to understand the
role of these receptor populations following chronic ethanol exposure. Cagetti et al. (2003)
found changes in synaptic GABAA receptor function in the hippocampus of rats that had
undergone chronic intermittent ethanol (CIE) treatment followed by 2 days of withdrawal. CIE
treatment decreases the frequency, rise time, amplitude, and decay time of mIPSCs in
pyramidal neurons from CA1, an overall change in GABAA receptor function that is consistent
with increased neuronal excitability. Interestingly, CIE eliminated the effects of diazepam on
the mIPSCs and increased mIPSC sensitivity to the α4 subunit-selective benzodiazepine
Ro15-4513. These pharmacological changes are consistent with a decreased expression of
α1-GABAA receptors and an increased expression of α4-GABAA receptors in the synapse.
Brief exposure (48–72 h) to the neuroactive steroid 3α,5α-THP may cause a similar effect since
there is a decrease in the decay time of mIPSCs recorded in hippocampal CA1 pyramidal cells
(Hsu et al. 2003). The decrease in mIPSC decay time was blocked by infusion of α4 subunit
antisense oligonucleotides into the hippocampus, suggesting that this change in synaptic
GABAA receptor kinetics is due to an increase in synaptic α4 subunit expression. Additionally,
tonic current is also modified after chronic ethanol exposure. Specifically, the effects of various
GABAA receptor modulators on tonic currents are reduced or ablated after CIE treatment
(Liang et al. 2004). Indeed, GABAA receptor ligands with selectivity for α4-GABAA receptors
exerted decreased effects on extrasynaptic currents as well as increased effects on synaptic
currents. Electron microscopy revealed an increase in synaptic localization of α4, but not δ
subunits on the dentate granule cells of CIE rats (Liang et al. 2006). Taken together, these
studies show that translocation of α4-GABAA receptors from an extrasynaptic to synaptic
localization may represent a mechanism of GABAA receptor adaptation to ethanol exposure.
Endocytosis and trafficking—Several mechanisms for GABAA receptor adaptation
following chronic ethanol exposure have been proposed that include alterations in gene
expression, post-translational modification, synaptic localization, intracellular signaling, and
neuroactive steroid responses to ethanol. The expression of GABAA receptors involves a highly
regulated process of synthesis, assembly, endocytosis, and recycling or degradation (see Fig.
1). Golgi-derived vesicles provide newly synthesized receptors to the cell surface, whereas
clathrin-coated vesicles mediate endocytosis of surface receptors that are ultimately degraded
or recycled back to the cell surface (Lodish et al. 1996). Alterations in the expression and
composition of various GABAA receptors could result from selective endocytosis, recycling,
and/or trafficking of newly synthesized receptors to the cell surface. Recent studies have shown
the importance of GABAA receptor trafficking on the surface expression of receptors following
ethanol exposure (Kumar et al. 2004). Altered GABAA receptor subunit composition and
expression on the cell surface following ethanol exposure is thought to contribute to the
development of ethanol dependence. Therefore, investigation of the mechanisms for altered
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GABAA receptor trafficking following ethanol exposure may provide novel targets for drug
development.
Chronic ethanol exposure selectively increases the internalization of α1-GABAA receptors into
clathrin-coated vesicles of the cerebral cortex with a corresponding decrease in these receptors
in the synaptic fraction (Kumar et al. 2003). In contrast, there is no change in the internalization
of α4-GABAA receptors into clathrin-coated vesicles although there is a significant increase
in α4 subunit peptide in the synaptic fraction following chronic ethanol exposure. Hence, the
regulation of intracellular trafficking following chronic ethanol exposure appears to alter the
subtypes of GABAA receptors on the cell surface. This may account for alterations in the
pharmacological properties of GABAA receptors that have been observed. Internalization of
GABAA receptors following chronic ethanol administration is mediated by clathrin and the
adaptor complex (AP) since the association of adaptin-α and clathrin with α1-GABAA
receptors in the intracellular fraction was increased following chronic ethanol administration
(Kumar et al. 2003). GABAA receptor β2 and/or γ2 subunits are required for recognition of
the receptor by the AP-2 that precedes clathrin-dependent endocytosis (Herring et al. 2003;
Kittler et al. 2005, 2008). Therefore, it is possible that PKC-mediated phosphorylation of
GABAA receptor subunits, receptor-associated proteins, and/or AP-2 following chronic
ethanol administration alters the recognition and endocytosis of GABAA receptors. Indeed,
chronic ethanol consumption results in increased expression of α4-, β2-, and β3-GABAA
receptor subunits in the cerebral cortex and all of these subunits contain consensus
phosphorylation sites for PKC (Macdonald 1995; Mohler et al. 1996; Wisden et al. 1991). In
contrast, α1-, α2-, and α3-GABAA receptor subunits are decreased in the cortex and these
subunits do not contain consensus phosphorylation sites for PKC. Hence, it is likely that
phosphorylation of GABAA receptor subunits can prevent internalization by blocking AP-2
binding. A recent study has shown that a single dose of ethanol can increase the internalization
of GABAA receptor α4 and δ subunits (Liang et al. 2007). However, this study did not
investigate the mechanism of GABAA receptor internalization. Therefore, investigation of
GABAA receptor endocytosis and trafficking following ethanol exposure is essential for
understanding the mechanisms of ethanol adaptations.
Trafficking of GABAA receptors can be regulated by many protein kinases, including PKC.
Chronic ethanol consumption decreases association of PKCγ with α1-GABAA receptors and
decreases expression of the α1 subunit at the cell surface. In contrast, chronic ethanol exposure
increases association of PKCγ with α4-GABAA receptors and increases expression of α4 at
the cell surface (Kumar et al. 2002). However, in the hippocampus, the association of PKCγ
with GABAA receptors is not altered and there is no alteration of α1 subunit expression
following chronic ethanol exposure (Kumar et al 2004). Therefore, it appears that association
of PKCγ with GABAA receptors and phosphorylation of subunits may influence the trafficking
of receptors in vivo following chronic ethanol administration. The increased association of
PKCγ with α4-GABAA receptors may phosphorylate GABAA receptor subunits and prevent
recognition of the receptor by AP-2, thus preventing its internalization. Indeed, it has been
shown that phosphorylation of GABAA receptor subunits reduces the binding of receptors with
AP-2 and subsequent internalization (Kittler et al. 2005, 2008). In addition, reduced PKC-
dependent GABAA receptor phosphorylation enhances receptor binding to the AP-2 and
promotes their endocytosis (Terunuma et al. 2008). Taken together, it appears that PKC-
mediated phosphorylation plays an important role in GABAA receptor cell surface expression
following chronic ethanol exposure.
GABAA receptor subunits contain phosphorylation sites for many protein kinases including
PKC, PKA, and fyn kinase. Phosphorylation can alter receptor function directly by changing
its conformation and/or indirectly by altering receptor expression. Since PKA and fyn kinase
alter GABAA receptor function, it is possible that these protein kinases are also involved in
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trafficking of GABAA receptors. For example, chronic activation of PKA in cerebellar granule
cells increases cell surface expression of GABAA receptor α1 subunit (Ives et al. 2002). In
addition, ethanol exposure alters expression and translocation of PKA (Diamond and Gordon
1994; Newton and Messing 2006; Pandey 1998). Hence, it is likely that PKA is also involved
in trafficking of GABAA receptors following ethanol exposure. However, to date, the role of
these protein kinases has not yet been studied in trafficking of GABAA receptors, especially
following ethanol exposure. Future studies will determine the specific role of various protein
kinases in GABAA receptor trafficking and resolve the precise mechanisms that account for
alterations in GABAA receptor function and expression following chronic ethanol
administration.
Alterations in ethanol-induced neuroactive steroid responses
Chronic ethanol consumption in rats results in blunted elevation of cerebral cortical 3α,5α-
THP (Morrow et al. 2001) and plasma and brain deoxycorticosterone levels following acute
ethanol challenge (Khisti et al. 2005) compared to pair-fed control rats. These findings suggest
that there is tolerance to ethanol-induced increases in neuroactive steroid levels. The loss of
ethanol-induced increases in neuroactive steroids may contribute to ethanol tolerance since the
elevations of neuroactive steroids are required for anxiolytic, sedative, anticonvulsant, and
cognitive-impairing effects of ethanol. Furthermore, since decreases in brain neuroactive
steroid levels are concomitant with decreases in plasma neuroactive steroid levels, it is likely
that the observed decreases in 3α,5α-THP and deoxycorticosterone levels are dependent on
blunted HPA axis activity. It is well known that chronic stress results in adaptation of the HPA
axis leading to decreases in stress-induced changes in the levels of corticosterone in rats
(Spencer and McEwen 1990). This blunting of the HPA axis is associated with a reduction in
corticotrophin releasing factor and adrenocorticotropin releasing hormone elevations
following ethanol challenge (Lee et al. 2001). Furthermore, repeated ethanol withdrawal also
leads to blunting of withdrawal-induced elevations in corticosterone levels (Borlikova et al.
2006). Thus, chronic ethanol administration induces adaptations of the HPA axis to promote
loss of stress-induced increases in GABAergic neuroactive steroids that contribute to the
regulation of homeostasis as well as ethanol sensitivity.
Chronic ethanol administration to rodents and humans produces tolerance to ethanol and cross-
tolerance to benzodiazepines and barbiturates. In contrast, ethanol-dependent rats are
sensitized to the anticonvulsant effects of 3α,5α-THP and 3α,5α-THDOC (Cagetti et al.
2004; Devaud et al. 1996; 1998). GABAA receptor sensitivity to 3α,5α-THP and 3α,5α-
THDOC is enhanced in the cortex, but sensitivity to alphaxalone is reduced in the hippocampus
(Cagetti et al. 2004) of ethanol-dependent rats, likely due to adaptations in GABAA receptor
expression described above. Since ethanol-dependent rats are sensitized to anticonvulsant
actions of neuroactive steroids, this class of compounds may be useful during ethanol
withdrawal. Indeed, neuroactive steroid therapy may have advantages over benzodiazepine
therapy since benzodiazepines exhibit cross-tolerance with ethanol. Further studies are needed
to explore this possibility.
Cross-talk with other neurotransmitter systems
As our understanding of cellular signaling pathways has advanced, it has become clear that
intracellular communication between receptors is critical for the coordinated function of cells.
There are multiple receptors expressed in every cell and their signals pass through a common
set of downstream effectors distinguished by multiple isoforms with slightly different
specificities and activities. The coupling among these pathways causes interactions among the
signals sent by the different classes of receptors. Recent molecular pharmacology studies have
demonstrated that ethanol acts on several neurotransmitter systems in the brain such as GABA,
NMDA, glycine, 5-hydroxytryptamine (5-HT; serotonin) 3, and nicotinic acetylcholine
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receptors as well as L-type Ca2+ channels and G protein-coupled receptors. Following the direct
actions of ethanol on receptors in the brain, a second wave of indirect effects is initiated that
subsequently leads to the typical acute behavioral effects of ethanol, ranging from disinhibition
to sedation and hypnosis, with increasing concentrations of ethanol. Therefore, a clear
understanding of the interactions between neurotransmitter receptors and their signaling
pathways is critical for understanding the mechanisms that underlie ethanol tolerance and
dependence.
Chronic ethanol exposure up-regulates NMDA receptor function and down-regulates
GABAA receptor function (see Crews et al. 1996 for review). Since many neurons contain both
NMDA and GABAA receptors and ethanol modulates both NMDA and GABAA receptors,
interactions between these receptors may play an important role in GABAA receptor adaptation
following ethanol administration. For example, administration of dizocilpine (a potent non-
competitive antagonist of the NMDA receptor) to rats, like ethanol, increases membrane
expression of GABAA receptor α4 subunits in hippocampus (Matthews et al. 2000b). The effect
on GABAA receptors following NMDA receptor activation is mediated by intracellular
Ca2+, since the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetra-acetic acid
(BAPTA) blocks the down-regulation of GABAA receptors following NMDA receptor
activation (Robello et al. 1997). In addition, the application of glutamate in hippocampal
cultures leads to translocation of PKCα and PKCγ to the plasma membrane and cytoplasmic
organelles, respectively, while PKCε localization remains unaltered (Buchner et al. 1999; Etoh
et al. 1991). Therefore, interactions of NMDA and GABAA receptors via intracellular signaling
pathways may play a vital role in GABAA receptor adaptation following chronic ethanol
administration. In addition, both NMDA and GABAA receptor activation, as well as ethanol
administration, alter brain-derived neurotrophic factor (BDNF) expression in neurons
(MacLennan et al. 1995; Obrietan et al. 2002; Tapia-Arancibia et al. 2001; Zafra et al. 1991).
BDNF has been shown to alter GABAA receptor function and expression. For example,
addition of BDNF in cortical cell cultures increases internalization of GABAA receptor α2, β2,
β3, and γ2 subunits (Brünig et al. 2001). In contrast, chronic application of BDNF increases
expression of GABAA receptor α6 subunit in cerebellar granular cells that is blocked by
concomitant application of ethanol (Ericson et al. 2003). Therefore, it is possible that ethanol-
induced altered trafficking and expression of GABAA receptors are partially mediated by
BDNF. Future studies on interactions of BDNF and GABAA receptor following chronic
ethanol exposure are needed to clarify the role of BDNF on ethanol-induced adaptations of
GABAA receptors.
Likewise, serotonin receptors, a primary target of ethanol action, can modulate GABAA
receptor function and expression via PKC-mediated pathways. Activation of 5-HT2 receptors
results in inhibition of GABAA receptor-mediated currents that can be blocked by the Ca2+
chelator BAPTA and the receptor for activated C-kinase (RACK) inhibitory peptide (RACK1-
rVI) (Feng et al. 2001). In addition, even though 5-HT3 is considered to be an excitatory
receptor, it is often expressed on inhibitory GABAergic interneurons, thus activation of 5-HT3
receptors by ethanol may contribute to some of the inhibitory actions of ethanol via increased
release of GABA (Lovinger 1999). Furthermore, activation of 5-HT3 receptors is also known
to increase the release of dopamine and glutamate (Lovinger 1999). Hence, it is clear that
activation of serotonin receptors can alter GABAA receptor function and expression. In
addition, recent studies have concluded that dopamine and β-adrenergic receptors can also
modulate GABAA receptors via PKA-mediated pathways (Flores-Hernandez et al. 2000).
Taken together, it is obvious that receptor cross-talk plays a vital role in modulation of
GABAA receptor function and expression following ethanol exposure.
Recent evidence indicates that many other neurotransmitter and cytokines may be involved in
ethanol-mediated alteration in GABAA receptor function and expression. For example, the
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mGluR5 antagonist 2-methyl-6-(2-phenyl-ethynyl)pyridine (MPEP) modulates the
GABAergic effects of ethanol (Besheer and Hodge 2005). Furthermore, the mGluR5 receptor
selective agonist (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) enhances GABA-gated
currents via post-synaptic effects in amacrine cells (Hoffpauir and Gleason 2002). Likewise,
cytokines may be involved in ethanol-mediated alterations in GABAA receptor function and
expression. Tumor necrosis factor α (TNF-α) concentrations in the brain are elevated by ethanol
administration (Crews et al. 2006; Kiefer et al. 2002) and this may contribute to a decrease in
GABAA receptor α1 subunit expression (Stellwagen et al. 2005) following chronic ethanol
exposure. Understanding of the mechanisms of ethanol dependence has been complicated by
the multiple actions of ethanol at various neurotransmitters and/or intracellular signaling
pathways. Hence, understanding of these interactions between neurotransmitter systems is
essential to the development of novel therapeutic targets for alcoholism.
Studies in non-human primates
In the past 10 years, there have been new studies on the effects of ethanol administration to
non-human primates that have also investigated effects on GABAA receptor function and
plasticity. Cynomolgus macaques (Macaca fascicularis) are a powerful model to study the
effects of long-term ethanol exposure as they will freely self-administer intoxicating quantities
of ethanol with drinking patterns that mimic human alcoholics (Grant et al. 2008b; Vivian et
al. 2001). Long-term ethanol self-administration by cynomolgus macaques alters the
pharmacological and functional properties of GABAA receptors by decreasing GABA potency,
but not efficacy, in the basolateral amygdala neurons. These alterations are associated with
decreased α2 and α3 subunit mRNA expression and with a trend for a decrease in α1 subunit
mRNA expression. No significant effect of gender or significant interaction between gender
and ethanol exposure is observed for any of the subunits examined. Furthermore, the mean
expression levels for both the α2 and the α3 subunits were significantly correlated with the
total amount of ethanol consumed (Floyd et al. 2004). In the same cohort of cynomolgus
macaques, Hemby et al. (2006) found significant decreases in mRNA expression for: α2, α4,
β1, β3, γ1, γ2, and γ3 in orbitofrontal cortex; β1, β2, γ1, and δ in dorsolateral prefrontal cortex;
but no changes in anterior cingulate cortex. In addition, Anderson et al. (2007) showed that
long-term ethanol self-administration reduces the sensitivity of amygdala GABAA receptors
to the benzodiazepine flunitrazepam and decreases mRNA expression of β1 and γ2 subunits.
Furthermore, there are significant effects of ethanol drinking on the γ2 subunit gene in males
but not females; however, there was no correlation between subunit mRNA expression and
total ethanol intake, suggesting that this gender adaptation is not related to drinking.
Interestingly, GABAA receptor density, measured by [3H]Ro15–4513 binding, does not differ
in the parietal and temporal cortex, cerebellum, or hippocampus after long-term ethanol self-
administration in these cynomolgus macaques (Sullivan et al. 2005). Overall, the effects of
ethanol in cynomolgus macaques differ from rat models in several aspects and suggest that
studies in non-human primates provide unique insights that may have more relevance for
human alcoholism.
Alcohol tolerance mechanisms
Although many people consume ethanol, the fact that only a select number of individuals
develop alcoholism remains enigmatic. Tolerance is thought to play a major role in the
progression towards alcoholism and may therefore contribute to risk for the disease. Tolerance
is defined as a reduced response to a constant amount of ethanol, such that a greater amount is
needed to obtain the same effect. Tolerance is complex because it can involve multiple
behaviors that respond to ethanol exposure in different ways. It can also be segregated as either
innate or acquired (i.e., requiring a previous ethanol exposure), with the latter being further
broken down into acute, rapid, and chronic tolerance, based on the temporal relationship
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between ethanol exposures and their duration (Kalant et al. 1971). Acute tolerance is
characterized by adaptations that occur immediately during exposure to ethanol. Rapid
tolerance is typically defined as tolerance manifested after a single exposure has been
eliminated from the system. Chronic tolerance involves various forms of multiple or continual
ethanol exposure paradigms. GABAA receptors are implicated in tolerance to ethanol’s effects.
For instance, in humans, sons of alcoholics exhibit decreased sensitivity to diazepam in eye-
movement tasks (Cowley et al. 1994), indicative of reduced sensitivity to GABAergic
stimulation. In animal studies, a considerable amount of work has been done to assess the role
of GABAA receptors in innate and acquired tolerance to ethanol, as described below.
Innate tolerance
Various studies using GABAA receptor modulators in inbred, selectively bred, and
recombinant inbred strains that differ in ethanol responses have correlated GABAA receptor
action to innate ethanol tolerance. For instance, mice selectively bred for differences in
diazepam responses also differed in ethanol responses. Mice that were more resistant to
diazepam were less ataxic to ethanol, compared to diazepam-sensitive mice (Gallaher and
Gionet 1988). The GABAA receptor agonist taurine may also be involved in different ethanol-
related responses in Sardinian alcohol-preferring (sP) rats versus non-preferring (sNP) rats.
Recent microdialysate studies indicate that sP rats had reduced ethanol-related taurine release
compared to sNP rats (Quertemont et al. 2000). Notably, alcohol-preferring rats were less
sensitive to the sedative-hypnotic effects of ethanol (Kurtz et al. 1996); therefore, it is possible
that differences in ethanol-related behaviors in these animals may be related to differences in
endogenous GABAA receptor ligands like taurine or responses to other GABAA receptor
modulators. Indeed, extrasynaptic receptors involved in tonic inhibition have recently been
shown to be sensitive to low concentrations of taurine (Jia et al. 2008a). However, sP and sNP
rats do not differ in their sedative-hypnotic responses to other benzo-diazepines and
barbiturates (Colombo et al. 2000), but sP rats are more sensitive to the sedative-hypnotic
effects of γ-hydroxybutyric acid (Colombo et al. 1998). It is possible that neuroactive steroids
may also be involved in innate responses in these animals. 3α,5α-THP and 3α,5α-THDOC are
increased in sP vs. sNP rats (Barbaccia et al. 1999). In other selectively bred animals,
withdrawal seizure-prone mice are not only found to be more sensitive to the anxiolytic effects
of ethanol than withdrawal seizure-resistant mice but they are also more sensitive to the
anxiolytic effects of pentobarbital (Atkins et al. 2000). In other studies, FAST & SLOW mice,
selectively bred for differences in locomotor stimulatory effects of ethanol, also differ in
responses to the convulsant effects of GABAA receptor modulators, and to the locomotor-
stimulant effects of benzodiazepines (Shen et al. 1998). Aside from selectively bred animals,
inbred strains of mice also suggest a role for GABAA receptors. C57BL/6J mice are not only
less sensitive to the sedative-hypnotic effects of ethanol than 129/SvJ mice but are also less
sensitive to the GABA agonist propofol (Homanics et al. 1999b). Interestingly, the same study
indicated that C57BL/6J mice are more sensitive to zolpidem and midazolam, but not
Ro15-4513 and pentobarbital. Besides pharmacologic modifiers, molecular biological
techniques have been used to assess the role of specific GABAA receptor subunits in innate
tolerance. Using a coding polymorphism difference in C57BL/6J and DBA/2J mice, different
lines of BXD recombinant inbred strains were used to determine whether variations in the gene
for the GABAA receptor γ2 subunit correlated with ethanol-related behaviors. BXD lines with
γ2 of DBA/2J origin were less ataxic on the screen test, but had greater ethanol-induced
hypothermia (Hood and Buck 2000). A trend was also noted for sedative-hypnotic effects as
well as a second motor ataxia test.
Acquired tolerance
Apart from innate tolerance, various inbred, selectively bred, and recombinant inbred rodent
strains, as well as genetically modified mouse models, have been used to assess acquired
Kumar et al. Page 18













ethanol tolerance. Acute functional tolerance (AFT) is a commonly used assay to assess acute
tolerance. AFT is defined as greater sensitivity to ethanol effects during the rising phase of the
blood ethanol curve than equivalent ethanol concentrations on the falling phase. However,
because accurately assessing blood ethanol concentrations on the rising phase is difficult due
to the immediate effects of ethanol, AFT is commonly assessed by measuring the ability of a
subject to exhibit a specific ethanol-related behavior (e.g., motor coordination, loss of righting
reflex) during successive ethanol exposures. Blood ethanol measurements are taken upon the
appearance of each behavior and the difference in blood ethanol level on the successive
measurements is indicative of acute tolerance.
AFT to the motor-impairing effects of ethanol is associated with a reduction in the ability of
ethanol to enhance muscimol-stimulated Cl− uptake in cerebellar microsacs (Wallace et al.
2007). Studies in GABAA receptor genetically modified models have shown that AFT to motor
incoordination is decreased in γ2S- and γ2L-GABAA receptor transgenics (Wick et al. 2000),
but does not differ in α1-, α5-, α6-, γ2L-, or δ-GABAA receptor knockout mice (Boehm et al.
2004b; Homanics et al. 1998, 1999a; Kralic et al. 2003; Mihalek et al. 2001). However, recent
work in α1-GABAA receptor (S270H, L277A) knockin mice suggests that α1-GABAA
receptors are involved in AFT to ethanol (Werner et al. 2009), since these mice display
decreased AFT to motor coordination.
GABAA receptor involvement in acute, rapid, and chronic ethanol tolerance has also been
assessed in various animal models. For instance, selectively bred mice that differ in diazepam
sensitivity also differ in rapid tolerance development. Mice that are more resistant to
diazepam’s effects also develop more rapid tolerance than diazepam-sensitive mice (Gallaher
and Gionet 1988). Inbred long-and short-sleep mice display differences in rapid tolerance.
Long-sleep mice that display a greater response to ethanol’s sedative-hypnotic effects also
develop greater rapid tolerance (Radcliffe et al. 2005). Indeed, these mice differ in GABAA
receptor inhibitory post-synaptic responses (Proctor et al. 2004), suggesting the involvement
of different GABAergic responses to ethanol. BXD mice have also been used to assess
tolerance. Assessment of the parental strains, C57BL/6J and DBA/2J, indicates that although
DBA/2J mice were more sensitive to ethanol’s motor ataxic effects, they also develop greater
AFT (Gallaher et al. 1996). Subsequent tests show quantitative trait loci (QTL) for ethanol
tolerance on chromosomes 9 and 11. While these studies did not identify a role for GABAA
receptors in tolerance, it is possible that subunits from the GABAA receptor subunit gene cluster
on chromosome 11 may be involved. Other studies show that mice selectively bred for ethanol
withdrawal severity do not differ in tolerance to ethanol’s hypothermic or sedative-hypnotic
effects (Crabbe and Kosobud 1986), although these mice exhibit differences in GABAA
receptor mRNA subunit expression (Keir and Morrow 1994) as well as differential changes in
subunit expression after chronic ethanol (Buck et al. 1991a). Together, these results support
the notion that various genes contribute to ethanol-related responses and that tolerance to
specific ethanol-related behaviors may be independent of withdrawal.
Genetically modified mice have also been used to assess the role of GABAA receptors in
chronic tolerance. Recent work suggests that α1-GABAA receptors are involved in chronic
tolerance to ethanol’s motor ataxic effects. GABAA receptor α1 (S270H, L277A) knockin mice
that are initially less sensitive to ethanol’s motor ataxic effects display decreased tolerance
after repeated ethanol exposure (Werner et al. 2009). Furthermore, β3-GABAA receptors
appear to play a role in chronic tolerance. β3 (N265M) knockin mice display enhanced
tolerance to ethanol’s sedative-hypnotic effects compared to controls (Sanchis-Segura et al.
2007). However, α6- and δ-GABAA receptor knockout mice do not differ from controls in
chronic tolerance to ethanol’s sedative-hypnotic effects (Homanics et al. 1998; Mihalek et al.
2001). Studies have also been carried out in genetically modified mouse models of genes known
to indirectly influence GABAA receptor function. Work has shown that PKCγ knockout mice
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did not develop chronic tolerance to ethanol’s sedative-hypnotic or hypothermic effects, but
this response was strain dependent (Bowers et al. 1999). PKCε knockout mice are resistant to
tolerance to motor-impairing effects of ethanol (Wallace et al. 2007). Further studies are needed
to establish the role of other GABAA receptor subunits and other GABAA receptor-associated
proteins in AFT as well as acute and chronic tolerance to other behavioral measures.
Tolerance and altered GABAA receptor function and regulation
Recent work has suggested that alterations in GABAA receptor expression may underlie
acquired ethanol tolerance. Studies indicate that a single high ethanol exposure results in
alterations in GABAA receptor subunit expression. One hour following ethanol exposure, α4
and δ surface expression is decreased in the hippocampal CA1 region, but no difference in total
subunit levels is found (Liang et al. 2007). This decrease in cell surface extrasynaptic receptors
is associated with a decrease in ethanol-enhanced tonic current. Furthermore, a significant
enhancement of surface expression of α4 and γ2 subunit proteins, as well as a decrease in α1
and δ subunits, was noted 2 days following ethanol exposure. Additionally, the ethanol-induced
increase in α4 subunit expression requires the binding of heat shock factor 1 at a downstream
site (Pignataro et al. 2007). These adaptive changes are accompanied by an increase in mIPSC
response to ethanol and decreased response to diazepam (Liang et al. 2007), suggesting that
the observed changes in receptor expression might underlie altered sensitivity to ethanol.
Furthermore, chronic ethanol exposure altered the recovery of baseline spontaneous neural
activity of medial septal/diagonal band of Broca neurons following GABA microiontophoresis
(Matthews et al. 2000a). These studies suggest that the observed changes in receptor expression
following chronic ethanol exposure might underlie altered sensitivity to ethanol and GABA.
Interestingly, the mIPSC effects were transient, and responses returned to normal after 2 weeks.
It is possible that these transient changes contribute to ethanol tolerance. Tolerance may be
restricted to selected brain regions or cell populations. Tolerance to ethanol’s effects in the
CA3 region of neonatal rats does not occur in slices exposed to ethanol for a prolonged period
(Galindo and Valenzuela 2006). Finally, inhibition of synaptic GABAA receptors results in the
incorporation of receptors diffusing from peri- and extrasynaptic sites (Thomas et al. 2005),
independent of receptors arising from intracellular stores. Overall, while not pinpointing the
exact role of GABAA receptors in ethanol action, these studies lend support to a possible role
of changes in GABAA receptor subtype expression contributing to tolerance to various ethanol-
related behaviors.
Adolescence
Adolescence (often defined as 12 to 20 years of age in humans) is a developmental period
highlighted by continued neurobiological development accompanied by changes in
personality. The neurobiological alterations include changes in neuronal networks, brain size,
and receptor number and compositions, while changes in personality include increased risk
choices and experimentation with drugs, including ethanol. In fact, increased drug use,
particularly ethanol, is a commonly noted factor at this developmental stage in humans (Kim
et al. 2008; Lim et al. 2007). The development of animal models to better understand the impact
of ethanol exposure during adolescence has rapidly proceeded in the last decade. The need for
animal models is obvious due to ethical and legal restrictions limiting ethanol research in
human adolescence. The terms adolescence and puberty are often used interchangeably. While
their timing overlaps, the terms are not synonymous (Sisk and Foster 2004; Spear 2000).
Puberty refers to gonadal maturation, while adolescence refers to a gradual period of maturation
of social and cognitive behaviors (Powell 2006; Sisk and Foster 2004). The precise timing of
adolescence in rodents is difficult to determine as there is no specific event signaling the
beginning and end of this developmental period and the boundaries vary depending on genetic
differences, gender, nutrition, and other environmental periods (Spear 2007). In rats, a
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conservative estimate of adolescence spans the period between postnatal days (PD) 28 and 42
(Spear 2007), but some harbingers of female adolescent development can begin as early as PD
20 and continue through PD 55 in males (Spear 2000, 2007). Studies investigating the effect
of ethanol in adolescent rats have used the period between PD 28 and 60 (Smith 2003), while
in mice, adolescence has been characterized as the period from PD 22 to 60 (Laviola et al.
2003).
Behavioral sensitivity
It has become clear that ethanol produces different behavioral responses in adolescence
compared to adults. Specifically, age modulates ethanol effects on motor incoordination,
anxiety, and cognitive function. Researchers have also shown that sensitivity to ethanol-
induced ataxia increases during ontogeny (Land and Spear 2004; Smith 2003; Spear and
Varlinskaya 2005). Specifically, adolescent rats exhibit less severe motor impairment
following ethanol exposure (Spear and Varlinskaya 2005; White et al. 2002a). Throughout
development, a natural increase in sensitivity to the motor-impairing effects of ethanol between
adolescence and adulthood emerges (Silveri and Spear 1998).
Besides motor ataxia, anxiety has been shown to play a role in the recurrence and initiation of
drinking behavior. Given the role of the GABAA receptor system in anxiety, it is reasonable
to surmise that the adolescent developmental period may be characterized by changes in the
anxiolytic effects of ethanol. Recent studies report attenuated withdrawal-related anxiety and
a lessened anxiolytic effect of ethanol in adolescent rats as measured in a social interaction test
(Doremus et al. 2003; Varlinskaya and Spear 2002, 2004). Interestingly, early adolescent
C57BL/6J mice show enhanced anxiety and greater anxiolytic response to ethanol on the
elevated plus maze (Hefner and Holmes 2007). In addition to potential species differences,
such contrary results are also likely confounded by different baseline levels of social interaction
and plus maze behavior between adolescence and adults. However, it is possible that lessened
anxiogenesis and increased anxiolysis during adolescence may also be a reflection of the
developmental state of the GABAA receptor system that underlies anxiety and may be a
contributing factor to problem drinking. Salimov et al. (1996) reported that ethanol
consumption during the adolescent period results in lower responsivity to novelty-induced
anxiety and stress. Again, these outcomes are predictive of a greater risk for problem drinking
as a result of ethanol exposure during the adolescent developmental period.
Ethanol impairs cognition, executive function, and attentional processes that involve several
brain regions. Among the constellation of cognitive impairments produced by ethanol, learning
and memory, which is hippocampal dependent, is particularly vulnerable to ethanol-induced
impairments (see Matthews and Silvers 2004 for review). However, the magnitude of these
cognitive impairments is age dependent. For example, early studies reported that acute ethanol
administration to adolescent rats produced greater learning and memory deficits compared to
adults (Land and Spear 2004; Markwiese et al. 1998) and this differential effect was dose
dependent (Acheson et al. 2001). However, the opposite effect (adolescents are less sensitive
than adults to the effects of ethanol) has also been reported (Land and Spear 2004; Rajendran
and Spear 2004). Regardless of whether adolescents are more or less sensitive to ethanol-
induced cognitive impairments, it is clear that ethanol affects the hippocampus of adolescents
differently than adults. Although the neurobiological mechanisms underlying this difference
are not yet elucidated, it is known that ethanol more potently attenuates hippocampal long-
term potentiation in brain slices from adolescent rats compared to adult rats (Pyapali et al.
1999). In addition, moderate ethanol doses (30 mM) enhance GABAA receptor-mediated
inhibitory tonic currents more potently in the dentate gyrus of adolescent rats compared to adult
rats (Fleming et al. 2007). These results demonstrate that innate differences, including
differences in GABAA receptors, exist in the hippocampus between adolescent and adult
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animals that likely underlie differential sensitivity to ethanol-induced impairments in
cognition.
Developmental alterations in GABAA receptor expression
Given that adolescent subjects differ from adults on many ethanol-related behaviors, it is
possible that the spatial and temporal changes in GABAA receptor subunit expression
throughout the developmental process may contribute to their phenotypic differences. Each
subunit exhibits unique developmental expression patterns based on regions and age,
suggesting that the expression and function of GABAA receptors during development may
differ from those found in adults (Henschel et al. 2008). GABAA receptor subunit expression
of α1, α2, α3, α5, and γ2 changes throughout development, reaching adult-like levels during
the third month of life (Jenkins and Simmons 2006). Immunoreactivity of α1 subunit is low at
birth and restricted to a few brain regions, with levels increasing during the first postnatal weeks
(Fritschy et al. 1994). In contrast, α2 subunit distribution is widespread in the superficial layers
(I–IV) of the neocortex (Yu et al. 2006) at birth. These levels decrease in some regions shortly
after the appearance of the α1 subunit and co-expression occurs briefly, with α1 eventually
replacing α2 subunit (Fritschy et al. 1994; Henschel et al. 2008). High levels of α3 subunit are
found within the frontal and perirhinal cortex, with up-regulation occurring from PD 10 to 30;
the α5 subunit has high expression throughout the brain, especially in the deep cortical layers
(Yu et al. 2006). The initial increases in α1, α2, α3, and γ2 found during the early postnatal
period change during development, and decrease until PD 60, while α5 levels decrease from
the high levels found in early development throughout the aging process (Yu et al. 2006).
Prominent throughout development, β2 and β3 immunoreactivity shows consistent levels in
both the neonatal and adult brain (Fritschy et al. 1994). In humans, a similar increase in α1 and
γ2 expression occurs with age in the temporal lobe, hippocampus, and basal ganglia (Kanaumi
et al. 2006).
Consistent with developmental shifts in GABAA receptor expression within specific brain
regions, the cerebellum displays levels of α6 subunit expression that increase with age and
expression of α1, γ2, β2, β3, and δ subunits that decreases with age (Gutiérrez et al. 1997).
Within the hippocampus, consistently high levels of γ2 and α5 subunit expression are found
across development, the α1 subunit shows decreasing levels through development and aging
(Yu et al. 2006), and levels of the δ subunit mRNA increase throughout development, with the
highest levels being found in adults (Laurie et al. 1992). Increasing levels of the δ subunit
mRNA across development are interesting, given the proposed link of δ-GABAA receptors to
low-dose ethanol sensitivity (Choi et al. 2008). Considering that adolescents are less sensitive
to ethanol’s motor ataxic effects compared to adults, and δ subunit mRNA levels are lower in
adolescents compared to adults, it is tantalizing to speculate that this subunit is a critical
mediator underlying the changes in ethanol’s effect on GABAA receptors across development.
Overall, because GABAA receptor subunit expression differs across development, it is likely
that changes in GABAA receptor stoichiometry underlie many of the developmental specific
effects of ethanol previously reviewed. Furthermore, chronic ethanol exposure alters
GABAA receptor mRNA and protein expression. As such, it is predicted that chronic ethanol
exposure during adolescence, when GABAA receptors are changing, should also alter
GABAA receptor protein expression in a manner that differs from the changes found following
adult ethanol exposure.
Ethanol intake and chronic ethanol exposure
Adolescent rats consume more ethanol than adults (Doremus et al. 2005). Indeed, adolescents
have been shown to consume two to three times more ethanol than adults relative to body
weight (Lancaster et al. 1996). Some variation in adolescent ethanol self-administration has
been found in consumption which may reflect methodological differences. When consumption
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is examined in a 24-h continuous access paradigm, adolescents exhibit a greater increase in
ethanol licking behavior over a 4-week period, compared to adults (Bell et al. 2006). However,
when voluntary ethanol self-administration is examined, adolescents consumed significantly
more ethanol when measured as g/kg body weight (Vetter et al. 2007). When the consumption
off the floor paradigm is used, adolescents show high levels of consumption that decrease
gradually into adulthood (Truxell et al. 2007). Overall, adolescents consume more ethanol than
adults; this difference is particularly evident when consumption is calculated relative to body
weight rather than proportion of overall consumption (Nance 1983). Complicating
interpretation of these results, rates of ethanol metabolism vary with age. Adolescents have
been observed to have faster rates of ethanol elimination than adults (Brasser and Spear
2002; Hollstedt et al. 1977); however, these results are not consistently found (Kelly et al.
1987; Silveri and Spear 2000). Additionally, these results have not been found to account for
the attenuated ethanol sensitivity shown by adolescents to many of the acute effects of ethanol
(Silveri and Spear 2000). The reported high levels of adolescent consumption may reflect age-
related changes in both the rewarding and aversive properties of ethanol (Vetter et al. 2007).
The subjective properties of a drug play a large part in consumption, abuse, and addiction
patterns. That is to say, the subjective experience of greater reward or less aversion as it relates
to a drug will lead to a greater risk of abuse. Assessment of the motivational properties of
ethanol has included the use of ethanol-induced conditioned place preference and ethanol-
induced conditioned taste aversion (CTA) (Chester and Cunningham 1999; Chester et al.
1998). Interestingly, although not without inconsistencies, GABAergic involvement has been
implicated in both of these tasks. For example, adult mice exposed to ethanol (via inhalation)
during the adolescent period show an attenuated ethanol-induced CTA (Chester and
Cunningham 1999; Smith 1989). Additionally, a chronic intermittent pattern of exposure,
resulting in multiple withdrawals during adolescence, exacerbates this attenuated CTA (Diaz-
Granados and Graham 2007; Graham and Diaz-Granados 2006). When subjects were
administered diaze-pam during the withdrawal periods in order to assess the role of possible
GABAA receptor withdrawal-related perturbations, the attenuation of the ethanol-induced
CTA was not dissimilar between diazepam-treated and control animals, suggesting that
GABAA receptor perturbations during withdrawal were not playing a role in the attenuation
of CTA. However, adult mice that were exposed to only diazepam during the adolescent period
showed the same attenuated CTA as adult mice exposed to only ethanol during adolescence.
Thus, the rewarding and aversive properties of ethanol, and therefore ethanol self-
administration, in adulthood are related to the interaction of these drugs with a developmentally
dynamic GABAergic system.
Chronic exposure to ethanol during adolescence has also revealed long-lasting changes in
hippocampal function and GABAergic neuroactive steroids. For example, CIE exposure to
high dose ethanol during adolescence does not impair spatial learning during the exposure
(Silvers et al. 2003a) but does produce cognitive tolerance to ethanol’s memory impairing
effects when animals are tested as young adults (Silvers et al. 2003b, 2006). However, the
cognitive tolerance is not permanent (Silvers et al. 2006) and may in fact lead to sensitization
of ethanol’s effect on memory following a long delay (White et al. 2000). Mirroring the
cognitive tolerance, CIE exposure during adolescence blunts ethanol-induced inhibition of
hippocampal pyramidal neurons, and this effect lasts into young adulthood (Tokunaga et al.
2006). Furthermore, chronic intermittent ethanol during adolescence also reduces hippocampal
3α,5α-THP levels in response to an ethanol challenge (Silvers et al. 2006) and this reduced
neuroactive steroid response directly mirrors the reduced cognitive and neurophysiological
effect following ethanol challenge. Therefore, it is likely that the prolonged cognitive and
neurophysiological tolerance found following chronic ethanol exposure during adolescence is
due to GABAergic mechanisms such as altered neuroactive steroid levels. Chronic ethanol
exposure has also altered other ethanol-related behaviors in adolescents. Although sensitivity
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to the motor-impairing effects of ethanol increases during development, repeated adolescent
binge drinking episodes prevent the emergence of this normal developmental change (White
et al. 2002b). Additional studies have also revealed a persistent tolerance to the sedative effects
of ethanol, resulting in continued attenuation of the animal’s loss of righting reflex (Silveri and
Spear 1998; Silvers et al. 2003b).
However, few studies have investigated whether chronic ethanol administration during
adolescence alters GABAA receptor structure or function. In fact, only three studies directly
compare the two age groups. Specifically, adolescent and adult rats do not differ on bicuculline-
induced seizure threshold (Wills et al. 2008), but differ on pentylenetetrazole-induced seizures
(Acheson et al. 1999) following chronic ethanol. However, chronic ethanol exposure for 1
month differentially altered GABAA receptor function in adult vs. adolescents as measured by
3α,5α-THDOC potentiated Cl− flux (Grobin et al. 2001). These limited studies suggest that
perhaps chronic ethanol might differentially alter GABAA receptor function when animals are
exposed during adolescence as compared to adulthood. However, additional work is clearly
needed on this topic.
Human alcoholics
Do the effects of chronic ethanol exposure in animal studies translate to humans? Behavioral
adaptations to ethanol in human beings mimic those observed in animal models. Further,
GABAergic neurotransmission is important for many behavioral actions of ethanol and several
studies in human alcoholics have highlighted changes in GABAA receptor function and
plasticity that resemble the adaptations found in animal models of ethanol dependence. For
instance, human alcoholics exhibit ethanol tolerance and benzodiazepine and barbiturate cross-
tolerance (Volkow et al. 1993; Woo and Greenblatt 1979). Early studies conducted in post-
mortem human brains have suggested the involvement of GABAA receptors: [3H]muscimol
binding density is greater in alcoholic cerebral cortex (Tran et al. 1981) and superior frontal
gyrus of non-cirrhotic alcoholics (Dodd et al. 1992) compared to healthy controls. Increases,
decreases, or no changes in benzodiazepine binding have been reported in several studies of
postmortem human alcoholics (Dodd 1995; Dodd et al. 1992; Freund and Ballinger 1988).
In vivo neuroimaging studies have shown that 1–6 months abstinent male ethanol-dependent
subjects have reduced binding of tracers for the GABA/benzodiazepine receptor in the frontal
cortex, measured by [11C]-flumazenil positron emission tomography (PET, Gilman et al.
1996) or [123I]-iomazenil single photon emission computed tomography (SPECT, Abi-
Dargham et al. 1998; Lingford-Hughes et al. 1998). A trend for a reduced [123I]-iomazenil
binding was reported in ethanol-dependent women withdrawn from ethanol with
benzodiazepines and abstinent from ethanol for at least 3 months (Lingford-Hughes et al.
2000). Using a [2-deoxy-2[18F]-fluoro-D-glucose] PET study, Volkow et al. (1997) found that
the inhibitory response to a lorazepam challenge was blunted in the orbitofrontal cortex and
cingulate gyrus in 8–11 weeks (during detoxification) abstinent ethanol-dependent subjects,
suggesting reduced GABA/benzodiazepine receptor function. However, this study did not
report withdrawal intensity. In contrast, after 1 week of abstinence from ethanol dependence,
higher [123I]-iomazenil binding to GABA/benzodiazepine receptors was observed in the
parietal, frontal, cingulated, temporal, insular, and occipital cortex of non-smoking (but not
smoking) ethanol-dependent subjects. Furthermore, the GABA/benzodiazepine receptor
availability in the cerebellum and occipital lobe at 1 week of abstinence was correlated with
the severity of ethanol withdrawal determined in the subjects every 6 h immediately after
admission to the clinic (Staley et al. 2005). Using [11C]-flumazenil PET to measure the
pharmacokinetics and pharmacodynamics of midazolam, Lingford-Hughes et al. (2005)
showed that ethanol dependence was associated with decreased midazolam-induced time
asleep in the absence of reduced benzodiazepine receptor occupancy in ethanol-dependent
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patients abstinent for at least 6 weeks. The authors hypothesized that this reduced sensitivity
in ethanol dependence may reflect a difference in the subunit profile of the GABAA receptors,
either as part of the vulnerability to, or as a consequence of their ethanol dependence. More
recently, Taylor et al. (2008) found that GABAA receptor function, assayed by midazolam-
induced slow saccadic eye movement and sedation, was not affected in ethanol-dependent
patients after 2 months of abstinence.
These changes in GABAA receptor function are accompanied by changes in receptor plasticity.
Several studies reported changes in GABAA receptor subunit expression in post-mortem brains
from human alcoholics, although results are often controversial. Lewohl et al. (1997) showed
that GABAA receptor α1 subunit mRNA expression was elevated in human alcoholic superior
frontal cortex, compared with non-alcoholic subjects, while α2 and α3 mRNA did not change.
Further, α1 protein expression was greater in the superior frontal compared to the motor cortex
of cirrhotic alcoholics, but no such difference was observed in controls or uncomplicated
alcoholics. In contrast, α3 peptide expression was lower in superior frontal than in motor cortex
of uncomplicated alcoholics (Lewohl et al. 2001). However, Mitsuyama et al. (1998) found no
difference in α1 and α4 subunits mRNA expression in frontal cortex between controls and
alcoholics, but β3 mRNA expression was elevated in non-cirrhotic alcoholics. These changes
were not accompanied by changes in α1, α4, or β2/3 protein expression between alcoholics
and controls. Others have reported no differences in mRNA expression for any β subunit
between alcoholics and controls (Buckley and Dodd 2004).
With the development of more sophisticated fine-mapping techniques, studies on GABAA
receptor subunit expression have been associated to specific genotypes. Thus, Dodd and
colleagues reported that the GABRB2 gene, which encodes for the β2 subunit, did not influence
the β2 subunit expression; rather, expression of β3 subunit was increased in controls with
GABRB2-1,2 genotype, but not in alcoholics with the same genotype (Dodd et al. 2004).
Furthermore, aldehyde dehydrogenase ADH1C, D2 dopamine receptor DRD2B, excitatory
amino acid transporter 2 EAAT2, and apolipoprotein E APOE genotypes modulate GABAA
receptor β subunit expression in superior frontal cortex toward a less-effective form of the
receptor (Dodd et al. 2004, 2006). Alleles associated with alcoholism also appear to reduce the
β3:β2 ratios in alcoholic’s superior frontal cortex. GABAA receptors with the β2 subunit are
less efficacious at mediating chloride flux in response to any GABA concentration, so this
subunit switching would have the effect of attenuating GABAA receptor-mediated inhibition
and may make this brain region more susceptible to the neuropathological consequences of
chronic alcoholism (Buckley et al. 2006). More recently, Haughey et al. (2008) reported that
levels of α2 subunit mRNA and protein in prefrontal cortex differed between subjects with
GABRA2 (the gene encoding the α2 subunit) genotypes, with higher levels of α2 subunit
expression in prefrontal cortex of subjects with the AA genotype compared to subjects with
the AG genotype (SNP rs279858); however, there was no difference between ethanol-
dependent and control subjects.
Polymorphisms in the genes encoding the GABAA receptor subunits have been linked to
ethanol response and risk for alcoholism in humans. Genes encoding the GABAA receptor
subunits are clustered in several chromosomal regions including 4p13–q11 (α2, α4, β1, and
γ1), 5q34–q35 (α1, α6, β2, and γ2), 15q11–q13 (α5, β3, and γ3), and Xq28 (α3, β4, and ε1)
(Enoch 2008). Results from the Collaborative Study on the Genetics of Alcoholism (COGA)
found an increased allele sharing among ethanol-dependent individuals in a region on
chromosome 4p that includes a cluster of four genes: GABRA2, GABRA4, GABRB1, and
GABRG1, encoding for α2, α4, β1, and γ1 subunits, respectively (Reich 1996; Reich et al.
1998). Since then, several studies have shown that GABRA2 is a key gene affecting the risk
for alcoholism. Edenberg et al. (2004) reported that single nucleotide polymorphisms (SNPs)
in the GABRA2 gene, but not other members in the gene cluster, were associated with both
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ethanol dependence and changes in β-frequency electroencephalogram (EEG). Brain
oscillations measured by EEG are a key phenotype in ethanol dependence: alcoholics and the
offspring of male alcoholics have increased power in the β-frequency band (13–18 Hz) of the
EEG (Costa and Bauer 1997). The association of GABRA2 markers with ethanol dependence
was subsequently replicated in several independent studies in different populations (Agrawal
et al. 2006; Bauer et al. 2007; Covault et al. 2004; Enoch et al. 2006; Fehr et al. 2006;
Lappalainen et al. 2005; Soyka et al. 2008). Within these studies, strong association of the
GABRA2 gene was found in European ancestry alcoholics without co-morbid drug dependence
or major depression (Covault et al. 2004), although results from the COGA study reported the
opposite (Agrawal et al. 2006). The association of GABRA2 with alcoholism was linked to
anxiety scores (Enoch et al. 2006) and to severity of ethanol withdrawal (Fehr et al. 2006;
Soyka et al. 2008), thus potentially influencing treatment outcome (Soyka et al. 2008). Indeed,
Bauer et al. (2007) found that genetic vulnerability at the GABRA2 gene influenced the ability
of different psychosocial treatments to reduce ethanol use.
Sensitivity to the acute effects of ethanol has also been linked to the GABRA2 gene (Haughey
et al. 2008; Pierucci-Lagha et al. 2005). Interestingly, individuals homozygous for the A-allele
at GABRA2 reported greater stimulant, sedative, and gastrointestinal subjective effects of acute
ethanol, compared with subjects with one or more G-alleles (the G-allele is overrepresented
among ethanol-dependent subjects; Covault et al. 2004). Administration of the neuroactive
steroid biosynthesis inhibitor finasteride antagonized some of the behavioral effects of ethanol
particularly among individuals homozygous for the A-allele, suggesting that neuroactive
steroids may be mediating the subjective effects of ethanol, like in rodent studies (Pierucci-
Lagha et al. 2005). The genetic association of ethanol dependence with GABRA2 is of
significant functional interest as animal studies have identified the α2 subunit as the primary
α subunit in limbic regions (McKernan and Whiting 1996). The α2 subunit mediates the
anxiolytic effect of benzodiazepines and barbiturates (Dixon et al. 2008; Rudolph et al.
1999) as well as the sedative-hypnotic, but not the sedative, effects of combined exposure to
ethanol and benzodiazepines in genetically modified mouse studies (Tauber et al. 2003).
More recent reports suggest that the association of the GABRA2 gene with alcoholism may
be complicated by moderate linkage disequilibrium of GABRA2 markers with a functional
genetic variation in the adjacent GABRG1 gene (Covault et al. 2008; Drgon et al. 2006; Ittiwut
et al. 2008). Indeed, Covault et al. (2008) reported that markers in the GABRG1 region on
chromosome 4 had the strongest association with ethanol dependence in the European
American population. The γ1 subunit-containing GABAA receptors show increased sensitivity
to neuroactive steroids compared to the γ2 subunit-containing GABAA receptors (Puia et al.
1993). This subunit is increased in ethanol-dependent rats (Devaud et al. 1995) that are
sensitized to the anticonvulsant effects of GABAergic neuroactive steroids (Devaud et al.
1996). Altered sensitivity to neuroactive steroids may affect ethanol sensitivity and therefore
modulate risk for ethanol dependence (Morrow et al. 2006). In addition to GABRA2, other
genes that encode for the GABAA receptor subunits have been associated with ethanol
dependence. Thus, on chromosome 4, association of the GABRB1 gene with alcoholism was
reported by several groups (Long et al. 1998; Parsian and Zhang 1999; Reich et al. 1998; Song
et al. 2003).
Results for markers in the GABAA receptor gene cluster on chromosome 5 are still
controversial, with associations reported in some samples, but not others (Dick et al. 2005;
Sander et al. 1999; Song et al. 2003). Thus, a positive association between ethanol dependence
and SNPs at the GABRG2 gene, encoding for the γ2 subunit, was observed in Scottish (Loh
et al. 1999), Finnish (Radel et al. 2005), and Japanese populations (Loh et al. 2000). Association
with the GABRB2 gene, encoding for the β2 subunit, was reported in Scottish (Loh et al.
1999), Finnish, and Southwestern Native American (Radel et al. 2005) populations. The
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GABRA1 gene, encoding for the α1 subunit, was associated with several drinking behavior
phenotypes, including history of blackouts, age at first drunkenness, level of response to
ethanol, and ethanol dependence (Dick et al. 2006). Associations with the GABRA6, encoding
for the α6 subunit, have been found in Scottish (Loh et al. 1999) and Finnish (Radel et al.
2005) populations. Furthermore, sons of alcoholics with the proline385 to serine polymorphism
at GABRA6 were less sensitive to the effects of ethanol and this polymorphism was a predictor
for the development of alcoholism (Schuckit et al. 1999). In the same subjects, this
polymorphism was also associated with reduced sensitivity to benzodiazepines (Iwata et al.
1999) and to the sedative effects of ethanol (Hu et al. 2005).
Finally, fine mapping of a GABAA receptor gene cluster on chromosome 15 reported modest
evidence of haplotypic association to ethanol dependence for the GABRG3 gene, encoding the
γ3 subunit (Dick et al. 2004). Moreover, Song et al. (2003) showed evidence for imprinting
association, with paternal, but not maternal, transmission of GABRA5 and GABRB3 genes,
encoding the α5 and β3 subunits, being associated with alcoholism.
Therapeutic implications for alcoholism
The discovery of new mechanisms of ethanol actions on GABAergic transmission over the
past 10 years opens new opportunities to intervene in the effects of ethanol on different aspects
of brain function. It is now possible to inhibit effects of ethanol by blockade of α4-GABAA
receptors or by inhibition of neuroactive steroid synthesis. The blockade of ethanol actions
may prevent ethanol-induced toxicity and/or facilitate increased consumption due to the loss
of ethanol sensitivity. Likewise, it is also possible to enhance ethanol sensitivity by targeting
α4-GABAA receptors with selective agonists or promoting neuroactive steroid synthesis.
While there are many advances in the molecular realm, it remains unclear whether it is
advantageous or disadvantageous to manipulate ethanol actions in humans. Future studies are
clearly needed to elucidate the therapeutic relevance of the advances of the last 10 years.
Future directions—unanswered questions
The advances of the past 10 years raise many new questions to explore. The identification of
ethanol binding sites on various GABAA receptor subtypes is yet unclear. The role of protein
kinases and phosphatases in ethanol actions are limited to too few GABAA receptor subtypes.
The coordinated actions of ethanol on multiple non-GABAergic targets that indirectly
influence GABAergic neurotransmission seem too complex to untangle with physiological
approaches. There is a lot of work to do.
Following chronic ethanol administration, there are specific adaptations of GABAA receptors
that appear to mediate increased CNS excitability. These mechanisms could be targeted for
therapeutic benefits. However, there are many unanswered questions in this realm as well.
What is the significance of changes in α2-, α3-, β2-, β3-, and γ1-GABAA receptors? Can we
modulate PKC and PKA interactions with GABAA receptors selectively? Would effects of
these protein kinases on other ion channels interfere with therapeutic strategies for modulation
of GABAA receptors? Can we target specific phosphorylation sites on specific proteins? Would
this interfere with the actions of other endogenous modulators?
Standing back to widen our perspective, must we ask if our animal models are adequate for
understanding the effects of ethanol on humans? Can we begin to model the genetic diversity
of humans, the neurobiology, endocrinology, and enhanced complexity of the human being?
Can we apply the knowledge gained from laboratory animals to develop treatments for ethanol
addiction, toxicity, and dependence? History would argue the answer is yes, so our challenge
is to choose the most important questions and persevere in the complexity of the problem to
make contributions to science and society.
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Mechanisms of GABAA receptor endocytosis and recycling. Endocytosis by clathrin-coated
vesicles requires adaptor complex-2 (AP-2) and clathrin binding to the receptor. AP-2 is
specific for endocytosis of surface proteins including GABAA receptors. First, AP-2 recognizes
and binds to GABAA receptors, then clathrin binds the complex and the receptor is internalized.
Phosphorylation of GABAA receptors can prevent AP-2 binding and subsequent
internalization. Internalized receptors may be recycled back to the cell surface or degraded
depending upon undefined intracellular signals. Protein kinases can alter many steps in the
receptor trafficking process. For example, PKC phosphorylation can alter recycling of
receptors, whereas PKA can increase surface expression of GABAA receptors. Adaptor
complex-1 (AP-1) transports newly synthesized receptors from the trans-Golgi reticulum to
the cell surface. Many proteins are required for intracellular trafficking of GABAA receptors.
For example, GABAA receptor-associated protein (GABARAP) is involved in trafficking of
GABAA receptors from the endoplasmic reticulum/Golgi complex towards the plasma
membrane and possibly also in vesicle-mediated cycling between the plasma membrane and
cytoplasmic pool of receptors. N-ethylmaleimide-sensitive factor (NSF) interacts with
GABARAP and influences intracellular trafficking of GABAA receptors. Gephyrin reduces
the diffusion of GABAA receptors from the membrane and facilitates their clustering at
synapses. Protein linking integrin-associated protein to cytoskeleton-1 (Plic-1) is also involved
in GABAA receptor trafficking and facilitates surface expression of the receptors (see Chen
and Olsen 2007 for review)
Kumar et al. Page 49







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Kumar et al. Page 52
Table 2
Effects of chronic ethanol exposure on GABAA receptor function in brain
GABAA receptor activity Alteration Reference
Cl− channel function ↓ Cl− fluxa,b (Kang et al. 1996; Morrow et al.
1988; Sanna et al. 1993; Ticku
and Burch 1980)
↔ Cl− fluxc,d (Allan and Harris 1987;
Tremwel et al. 1994)
↓ mIPSC areac (Cagetti et al. 2003; Liang et al.
2004; Liang et al. 2006, 2007)
↓ Tonic currentc (Liang et al. 2007)
Ethanol-enhanced Cl− channel
function
↓ Cl− fluxd (Allan and Harris 1987; Morrow
et al. 1988)
↑ mIPSC enhancementc (Liang et al. 2006, 2007)
↓ Tonic current enhancementc (Liang et al. 2006, 2007)
TBPS binding ↑ Bindinga (Sanna et al. 1993)
Barbiturate modulation ↓ Pentobarbital-mediated Cl−fluxa (Morrow et al. 1988)
Benzodiazepine modulation ↓ Flunitrazepam Cl− Fluxd (Buck and Harris 1990; Sanna et
al. 1993)
↓ Diazepam-enhanced mIPSCsc (Cagetti et al. 2003)
↓ Diazepam-enhanced tonic currentc (Liang et al. 2004)
↓ Zolpidem-enhanced mIPSCsc (Liang et al. 2004)
↓ Zolpidem-enhanced tonic (Liang et al. 2004)
currentc
Ro15-4513 modulation ↑ Cl− flux inhibitiona (Buck and Harris 1990)
↑ Bindingc,d (Mhatre et al. 1988; Cagetti et al.
2003)
↑ mIPSCs enhancementc (Cagetti et al. 2003)
↓ Tonic current enhancementc (Liang et al. 2004)
THIP modulation ↓ Enhancement of tonic currentc (Liang et al. 2004)
↑ mIPSCsc (Liang et al. 2004)
Neuroactive steroid modulation ↑ 3α,5α-THP Cl− fluxa (Devaud et al. 1996)
↑ 3α,5α-THDOC Cl− fluxa (Devaud et al. 1996)
↓ Alphaxalone mIPSC enhancementc (Cagetti et al. 2003)
↑ Increased, ↓ decreased, ↓ abolished, ↔ no change
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